Next Article in Journal
A 512-Ch Dual-Mode Microchip for Simultaneous Measurements of Electrophysiological and Neurochemical Activities
Next Article in Special Issue
Advancing Healthcare: Synergizing Biosensors and Machine Learning for Early Cancer Diagnosis
Previous Article in Journal
Layer-by-Layer Combination of MWCNTs and Poly(ferulic acid) as Electrochemical Platform for Hesperidin Quantification
Previous Article in Special Issue
Non-Perturbative Identification and Subtyping of Amyloidosis in Human Kidney Tissue with Raman Spectroscopy and Machine Learning
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation

School of Integrative Engineering, Chung-Ang University, 84 Heukseuk-ro, Dongjak-gu, Seoul 06974, Republic of Korea
*
Author to whom correspondence should be addressed.
Biosensors 2023, 13(5), 501; https://doi.org/10.3390/bios13050501
Submission received: 23 February 2023 / Revised: 20 April 2023 / Accepted: 22 April 2023 / Published: 26 April 2023
(This article belongs to the Special Issue Nano-Biosensors for Detection and Monitoring)

Abstract

:
Non-invasive, non-destructive, and label-free sensing techniques are required to monitor real-time stem cell differentiation. However, conventional analysis methods, such as immunocytochemistry, polymerase chain reaction, and Western blot, involve invasive processes and are complicated and time-consuming. Unlike traditional cellular sensing methods, electrochemical and optical sensing techniques allow non-invasive qualitative identification of cellular phenotypes and quantitative analysis of stem cell differentiation. In addition, various nano- and micromaterials with cell-friendly properties can greatly improve the performance of existing sensors. This review focuses on nano- and micromaterials that have been reported to improve sensing capabilities, including sensitivity and selectivity, of biosensors towards target analytes associated with specific stem cell differentiation. The information presented aims to motivate further research into nano-and micromaterials with advantageous properties for developing or improving existing nano-biosensors to achieve the practical evaluation of stem cell differentiation and efficient stem cell-based therapies.

1. Introduction

Stem cells can differentiate into specific cell subtypes, which has resulted in the development of tissue engineering and regenerative medicine [1,2]. Due to stem cells’ ability to produce cells in vitro that are associated with the physiological functions of specific tissues, stem cell therapy has emerged as a potential solution for many diseases that are difficult to treat with conventional chemotherapy over the past few decades [3,4,5,6]. There have been 40,183 research papers about stem cell therapy published between 1971 and 2021; many of these studies demonstrated its clinical potential. However, the only stem cell therapy approved by the United States Food and Drug Administration to date is haematopoietic (or blood) stem cell transplantation [7,8,9,10].
There are many challenges in the development of stem cell therapy, including low differentiation efficiency, differentiation into undesired cell subtypes, carcinogenesis, and post-transplant inflammatory response [11,12]. Therefore, many stem cell differentiation studies have been conducted to (i) understand the developmental stages of stem cell differentiation, (ii) control stem cell behaviour in vitro, and (iii) enhance stem cell differentiation efficiency [13,14,15,16]. Consequently, a need for measuring stem cell differentiation using a variety of analytical methods has arisen. These techniques include polymerase chain reaction (PCR), immunocytochemistry, flow cytometry and Western blot (WB), which have been widely used with biomarkers, such as proteins, ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) [17,18,19,20]. However, these techniques are destructive, laborious, and costly; therefore, they are inappropriate for the quantitative and qualitative analysis of differentiated cells prearranged in therapeutic transplantation [21]. Hence, non-destructive and real-time monitoring of cell differentiation is necessary for efficient stem cell therapy. Many biosensing and nanotechnology methods have been proposed for the non-invasive monitoring of stem cell differentiation, such as impedance and Raman spectroscopy, deep learning-based approaches, electrochemical immunoassay biosensors, and electroluminescence [22,23,24,25,26,27,28,29,30,31,32,33]. In particular, electrochemistry-based sensing methods, such as impedance spectroscopy and electroluminescence, have been demonstrated as analytical techniques that selectively detect target materials through electrical signals generated from the redox reaction of analytes. These techniques have the following advantages: (i) facile, (ii) inexpensive, (iii) simple, portable analytical devices, and (iv) non-invasive [34,35,36,37,38]. Similarly, optical sensing methods, such as fluorescence, near-infrared (NIR), and Raman spectroscopy, can selectively detect the optical properties or signals of target materials. These methods have the following advantageous features: (i) high selectivity, (ii) flexibility, and (iii) non-invasive [39,40,41,42,43,44].
The medium for in vitro stem cell cultivation contains cells with many organelles, but also several types of proteins, small molecules, and other chemicals; this means that the analytical conditions for cell-based sensing are highly complex [41,45]. Therefore, improving sensing performance, including sensitivity and selectivity towards target analytes, is essential for the accurate and sensitive label-free monitoring of stem cell differentiation with electrochemical or optical-based sensors. More specifically, a highly sensitive sensing capability for differentiation-associated targets is required to quantitatively analyse how much differentiation was induced from the stem cells in real-time. In addition, to qualitatively analyse whether specific differentiation into desired cell subtypes has been induced during stem cell differentiation, selectivity for the analytes is a key indicator.
Various nano- and micromaterials have been used to modify sensor surfaces to improve performance, including sensitivity, selectivity, and reliability [44,46]. For instance, highly conductive metal nanomaterials, such as gold nanoparticles (AuNPs) and silver nanoparticles (AgNPs), and carbon-based conductive materials, such as graphene oxide (GO), have excellent electrical or electrochemical properties and are widely used in electrochemical sensors [47,48]. In addition, three-dimensional (3D) micromaterials, such as microelectrode assays and microfluidics, have been used to improve electrochemical sensors’ performance by increasing the active surface area [49,50,51]. In the case of Raman spectroscopy-based sensors, two-dimensional (2D) or 3D combinations of metal nanoparticles with good optical properties and carbon-based conductive materials have been used to improve the sensitivity [52,53]. However, each electrochemical and optical-based sensor’s sensing mechanism is different; therefore, the strategies for improving the sensing performance and capabilities and the techniques for sensor surface modification are different.
This review highlights and compares recent studies on non-invasive and real-time monitoring of stem cell differentiation, including neurogenesis, cardiomyogenesis, osteogenesis, and adipogenesis (Figure 1). In addition, various biosensors fused with specific analysis technology, such as electrochemistry and optical sensing, and various nano- and micro materials, such as AuNPs, AgNPs, upconversion nanoparticles (UCNPs), autofluorescence probes, nucleic acids, microfluidic systems, and microelectrode arrays, are reviewed and compared (Table 1).

2. Electrochemical Sensors

2.1. Gold Nanoparticle-Based Electrochemical Sensors

Gold’s conductivity is 4.11 × 107 S/m, which is highly favourable for electrochemical sensors [54]. Moreover, gold is colloidal in AuNPs, which has various advantageous features for electrochemical sensors [55,56,57,58,59,60,61,62,63]. For example, AuNPs are easy to synthesise and can be conjugated with multiple biomolecules, such as protein ligands, nucleic acids, and antibodies, which can enforce the intrinsic properties of the AuNPs [64,65,66]. Moreover, it has been reported that AuNPs are non-cytotoxic, cell-friendly materials with great potential for sensing biomolecules in a cell-based environment and for cell cultivation platforms [67,68,69,70,71,72]. Therefore, AuNPs have been widely used to develop electrochemical sensors with new nanostructures or modify existing electrochemical electrode surfaces at the nanoscale.
Many studies have described AuNP-based electrochemical sensors capable of sensing stem cell differentiation. For example, Suhito et al. developed an electrochemical AuNP-based electrochemical nano-biosensor to identify the differentiation of embryonic stem cells (ESCs) [59]. To fabricate this sensor, AuNPs were densely deposited on a transparent indium–tin oxide-coated glass electrode through electrochemical deposition. The study’s cell detection results using differential pulse voltammetry (DPV) showed that the undifferentiated ESCs generated relatively strong electrochemical signals compared with differentiated ESCs-derived endothelial cells. Interestingly, this sensor could sensitively measure ESCs based on the high electrical conductivity of gold, detecting at least 12,500 cells on one platform. Moreover, it was shown that this sensor could ensure ESCs’ adhesion and long-term cell growth, suggesting its application as an ESCs’ cultivation platform and a platform for electrochemically monitoring various stem cell differentiation.
In another study, Lee et al. described a AuNP-based nano-biosensor for non-invasive, real-time monitoring of the osteogenesis of mesenchymal stem cells (MSCs) [73]. Specifically, this sensor comprised a 3D AuNP-based nanoarray; the surface of the gold nanoarray was modified with GO. This nanostructure efficiently increased gold’s electrical conductivity and electron transfer rate through GO modification, allowing the detection of p-aminophenol (PAP) produced by the enzymatic reaction occurring in MSCs’ osteogenesis. Furthermore, this study observed that this nanoarray provided physicochemical cues beneficial to cellular adhesion and osteogenic differentiation. As a result, this gold-based electrochemical sensing platform detected the anodic signals of PAP using cyclic voltammetry (CV), quantitatively monitoring differentiation during 3 weeks of osteogenesis.
In 2021, a AuNP-based sensing platform was developed that monitored the differentiation of stem cells and controlled their cell differentiation by regulating cellular adhesion (Figure 2a,b) [74]. This sensor was based on a nanoassembly in which AuNPs and Arg-Gly-Asp peptide (RGD) ligands were conjugated on the surface of magnetic iron (II, III) oxide (Fe3O4) nanoparticles. Specifically, the magnetite mediated the control of falling and rising ligand movements via linker compression and stretching, thereby regulating MSCs’ integrin expression pattern, cellular adhesion, and consequent osteogenic differentiation. Additionally, due to the high electrical conductivity of the AuNP nanoassembly-based sensor, osteogenic differentiation could be monitored by sensitively measuring PAP’s redox using CV.
In 2022, a AuNP-based electrochemical nano-biosensor capable of sensing the generation process and maturity of kidney organoids produced through the differentiation of induced pluripotent stem cells (iPSCs) was developed (Figure 2c,d) [75]. Moreover, the variations of organoids led to the need for a non-destructive evaluation of their maturity [76,77,78]. Therefore, this sensor was developed to assess the iPSCs differentiation into kidney organoid by sensitively detecting the electrochemical signals originating from the organoids through a gold film structure on which there was electrochemically deposited AuNPs. Interestingly, while monitoring the kidney organoid generation on this sensor, two peaks were detected in the DPV results. Specifically, it was confirmed that the first peak corresponded to cell outgrowth, while the second peak differed depending on the maturity of kidney organoids. A strong second peak was observed for organoids with distinct tubular structures. These results demonstrate that this electrochemical sensor could detect the successful production of kidney organoids in a label-free, non-destructive manner.
In general, studies have shown that AuNPs can be applied to develop electrochemical sensors that sensitively detect the target analytes involved in stem cell differentiation because of AuNPs’ excellent electrical conductivity, versatility, and ease of synthetic manipulation with various biomolecules and nanomaterials.

2.2. Nucleic Acid-Based Electrochemical Sensors

Nucleic acids, including DNA and RNA, are biopolymers composed of nucleotide units [79]. Nucleic acid molecules have specific nucleotide sequences, which comprise of the bases of adenine, thymine, cytosine, and guanine, that can bind strongly with complementary base-pair sequences. The intrinsic properties of nucleic acids have the potential as nanomaterials for biosensors [74,80,81,82,83], as they impart high selectivity in terms of the capability to detect target molecules selectively. In addition, nucleic acid-based aptamers can be developed as ligands for target materials through the systematic evolution of ligands by exponential enrichment technology [84,85]. These aptamers can be developed faster and cheaper than antibodies. Moreover, aptamers have unique 3D structures (e.g., loop, stem, quadruplex, bulge, hairpin, and pseudoknot) through the nucleotide sequence alignment of the nucleic acids; this allows the aptamers to bind more strongly and selectively to the target [86,87,88]. In addition, nucleic acid materials can be chemically conjugated to fluorescent or electrochemical probes, giving a stronger signal and higher affinity toward analytes.
Park et al. [89] described a microelectrode based on carboxylated polypyrrole nanotubes conjugated with aptamers capable of evaluating the neuronal maturation of neurons. These authors showed that the aptamer-based sensor could sensitively and selectively measure dopamine (DA) exocytosis as a neuronal function. To improve the sensor’s performance, the DA sensitivity according to the carboxylated polypyrrole nanotube diameter was first analysed. Then, the optimised aptamer-based sensor was evaluated for DA-sensing performance using amperometry, which showed an excellent limit of detection (LOD) of 100 pM. Furthermore, the sensor could electrochemically distinguish DA in the presence of other neurotransmitters, such as norepinephrine, serotonin, and phenethylamine. This study demonstrated that the developed sensor could electrochemically detect exocytotic DA released from neuronal cells due to DA’s high sensitivity and selectivity. The study’s results suggested the possibility of aptamer-based electrochemical sensors to monitor the neural differentiation process of stem cells.
A nucleic acid-based electrochemical sensor capable of monitoring cardiomyocyte differentiation was reported in 2021 [90]. This nucleic acid-based sensor contained hybrid materials, including short DNA domains and peptide motifs that bind complementarily to cardiomyocyte-specific regulatory proteins. Notably, this sensor showed a low level of LOD of 0.42 pg/mL. In addition, the sensor selectively detected electrochemical signals from cardiac troponin (cTnl) as a target molecule in the presence of other proteins, including human serum albumin and human brain natriuretic peptide. Due to the sensor’s high affinity and sensitivity to cTnl, it was possible to determine the cTnl expression level through electrochemical signals measured from cardiomyocytes differentiated from MSCs. In addition, the electrochemical signal for cTnl obtained while monitoring the cardiomyocyte differentiation process was consistent with the result of flow cytometry, validating the high reliability of this sensor.
In another study, an aptamer-based electrochemical sensor was developed to evaluate the neuronal function at the single cell level [91]. This sensor comprised micro-wells, DA aptamers, and co-reactant-embedded polymer dots (Pdots). The sensor’s embedded Pdots provided electrochemical luminescence signals, which served to visualise the electrochemical DA signal (Figure 3a,b). The hybrid structure of this sensor allowed it to capture a single or a small number of differentiated cells inside a micro-well, which then selectively detected the DA released from the captured neurons using the DA aptamer. This sensor exhibited stable cell viability as a cell cultivation and differentiation platform with low cell toxicity. In addition, this sensor demonstrated a low LOD of 53 pM DA (Figure 3c,d) and was capable of evaluating the amount of DA exocytosis.
Nakatsuka et al. reported a DNA aptamer-based nanopipette capable of monitoring the differentiation process of iPSCs into serotonin neurons [92]. This sensor was used to electrochemically detect 5-hydroxytryptamine (5-HT) release from serotonin neurons as differentiated cells. In addition, the nanopipette form of the sensor allowed size exclusion of non-specific proteins in complex culture medium environments, further enhancing the sensor’s 5-HT selectivity. Specifically, this sensor was able to detect 5-HT of less than 3 nM using fast scan CV, which is an excellent sensing capability for DA, similar to the sensing capability of enzyme-linked immunosorbent assay (ELISA). Above all, this sensor was able to detect 5-HT released at the cellular level through the introduction of an aptamer capable of binding specifically to 5-HT.
These studies support that nucleic acid materials can greatly improve electrochemical sensing ability, especially target selectivity, through their specific binding sites. In addition, nucleic acid materials can be combined with other types of biomolecules or sensing probes through chemical conjugation to provide various 3D ligands, which can improve electrochemical sensors’ capabilities.

2.3. Carbon Nanomaterial-Based Electrochemical Sensors

Carbon nanomaterials (CNPs), such as graphene and its derivatives, fullerene and carbon nanotubes (CNTs), and nanofibres are composed of chemical structures in which carbon atoms are combined through sp2 hybridisation, resulting in the delocalisation of electrons [93]. The intrinsic properties of CNPs depend on their configuration and include good thermal stability, mechanical properties and chemical resistance. Furthermore, due to their structural characteristics, they have good electrical properties, including electron mobility and electrical conductivity. Moreover, CNPs can be synthesised into specific 3D structures, such as CNTs, and sheet forms, such as graphene. In addition, CNPs are biocompatible and can improve cellular functions, for example, cell adhesion and proliferation, making them suitable for stem cell cultivation platforms [94,95,96,97,98,99,100,101,102,103].
In a 2021 article, Castagnola et al. describe a graphene-based electrochemical nanosensor to evaluate neuronal function [104]. This sensor comprised graphene flakes with a 3D arrangement via photolithographic processes. This sensor showed high electrochemically active area enhancement. Specifically, the electrochemically active area of the sensor was about 88 times higher than that of conventional carbon fibre electrodes. The sensor sensitively and selectively detected DA as a target analyte using fast scan CV to evaluate neuronal function; the LOD for DA was calculated to be approximately 364.44 nM. Furthermore, the sensor was demonstrated to discriminate between serotonin and DA. Overall, this sensor’s enhanced electrochemical properties for sensitive and selective sensing of DA suggested that neurogenesis could be monitored in real-time by sensing DA released from neurons in vitro.
Vasudevan et al. [105] developed a nanosensor based on CNPs (Figure 4a). Specifically, this sensor was composed of carbon fibre, which detected DA released from neural stem cell-derived dopaminergic neurons and promoted neurogenesis in vivo based on optogenetics as an optical fibre. To improve the electrochemically active surface area of the sensor, a 15 μm thick polyimide buffer layer was coated onto the surface of a silica-based optical fibre; then, this layer was processed to form of 8 μm thick pyrolytic carbon fibre surrounded by cladding. Subsequently, human neural stem cells (hNSCs) were cultured on the sensor surface and differentiated into dopaminergic neurons to detect DA exocytosis electrochemically using an amperometric method. According to the amperometric results, the electrochemical signal towards DA was not confirmed from undifferentiated cells on the sensor surface. However, a clear electrochemical current peak towards DA was confirmed from the differentiated cells (Figure 4b,c). Moreover, as a result of monitoring the DA signals on the sensor surface during the 10-day differentiation period, it was observed that the DA signal gradually improved according to dopaminergic differentiation. These results suggested that the sensor could monitor dopaminergic differentiation non-invasively.
Similarly, Pham Ba et al. constructed a CNT-based nanosensor to monitor neuronal differentiation [106]. This sensor’s Nafion®-radical layer was composed of CNT transistors and was demonstrated to selectively detect DA in the presence of the interfering molecules acetylcholine and glutamine. In addition, it was confirmed that neuronal cells could be normally attached and cultured on the sensor surface. Moreover, an amperometric response to DA was observed immediately after potassium chloride (KCl) stimulation from neurons cultured on the sensor surface. Furthermore, the sensor obtained different amperometric responses to DA by adding different concentrations of KCl, suggesting that the sensor could discriminate between different degrees of DA exocytosis.
The previously mentioned studies support that carbon nanomaterials, including graphene, carbon fibre, and CNT, can be actively utilised to construct excellent sensing platforms with high electrical properties. In particular, nanosensors based on the graphene family have been demonstrated to monitor neuronal differentiation by sensitively and selectively sensing DA through π-π stacking. Moreover, CNPs’ biocompatibility and high sensing capability make them suitable for stem cell cultivation platforms and non-invasive monitoring of various types of stem cells, such as ESCs and MSCs.

2.4. Microfluidic System-Based Electrochemical Sensors

Microfluidic systems refer to systems in which fluid can flow through micro-scale channels fabricated on a substrate [107]. The microfluidic system has the advantage that it can be performed on a single chip under various conditions in a short time using only a small volume of reagents. Due to these structural features, microfluidic systems have been actively applied as biosensors [108,109,110]. Furthermore, given that the microchannel in microfluidic systems enables electrochemical species in the analytes to be confined near the electrochemical electrodes, they are advantageous to electrochemical sensing with high performance [111]. Above all, microfluidic systems can mimic the cellular microenvironment, which can be applied as a stem cell cultivation platform [112].
An example of an electrochemical sensor based on a droplet microfluidic system capable of sensing osteogenic differentiation was described by Fan et al. in 2019 [113]. This sensor could detect the impedance of a single cell; therefore, it was possible to analyse the differentiation of stem cells non-invasively without a label. The sensor detected a difference between the impedance of undifferentiated and differentiated cells. As osteogenic differentiation progressed, the variation in cell impedance decreased. In addition, the average impedance decreased as the differentiation progressed. Conversely, the capacity of the cells analysed on the sensor gradually increased with differentiation. These results were consistent with the fact that calcium ion channels were gradually formed on the cell membrane following osteogenic differentiation.
In 2020, a brain-on-a-chip device based on a microfluidic system capable of analysing neural differentiation was developed [114]. This platform’s design structure included three isolated compartments, suggesting that this structure was suitable for pharmacological manipulations, and a plastic lid and a specific gas supply chamber to build a gas supply system. It was validated that neurons could be cultured and maintained for up to 98 days on the platform. In addition, it was confirmed that neurons were differentiated normally on the device with positive expression of axonal and dendritic markers and that their neuronal networks were formed normally. Furthermore, the spike train tiling coefficient was successfully measured from the neuronal network of neurons differentiated on the platform.
Another study by Lee et al. described a microfluidic system-based sensing and cultivation platform capable of electrochemically analysing the cellular function of cardiomyocytes differentiated from iPSCs [115] (Figure 5a). Interestingly, the platform developed contained an aptamer and a gold-based microfluidic system. The functionality of cardiomyocytes could be electrochemically monitored by selectively sensing markers, such as troponin T, creatine kinase, and human epidermal growth factor receptor 2; these markers are related to the functionality of cardiomyocytes (Figure 5b). In addition, to investigate the interaction between cardiac and heart cancer tissues cultured on the platform, troponin secreted from each cell was detected after single or dual interaction with the platform on which each tissue was cultured (Figure 5c). Results showed that troponin released from healthy cardiac tissues increased in the single and dual platforms. In contrast, troponin released from healthy tissues on the dual platform was lower than from cells that did not interact with heart cancer tissues. In addition, cell functionality was evaluated electrochemically by measuring biomarkers released from healthy cardiomyocytes and heart cancer cells on the aptamer and microfluidic system-based platforms. The results obtained on the platform were consistent with ELISA results.
Therefore, it can be concluded that microfluidic systems are effective micromaterials for constructing sensing platforms for the non-invasive and label-free monitoring of stem cell differentiation. In particular, microfluidic systems are suitable for application as a stem cell culture platform and can considerably improve the performance of existing electrochemical sensors.

2.5. Microelectrode Array-Based Electrochemical Sensors

Microelectrode arrays refer to micromaterials in which multiple micro-scale electrodes are arranged on a single substrate [116]. Microelectrode arrays are based on a 3D structure that improves and increases the electrochemically active area in which analytes participate in the redox reaction, providing a high sensing performance [117]. In addition, considering that a plurality of electrodes is spatially arranged in a microelectrode array, it is possible to analyse signals of cells by position on a single substrate and to analyse single cells and spheroids electrochemically [118].
The literature reports that microelectrode array-based electrochemical sensors that can non-invasively monitor stem cell differentiation have been developed. For example, a microelectrode array that electrochemically monitors cardiomyocyte differentiation has been described [119]. This platform was designed to culture iPSCs for an extended period and to perform qualitative and quantitative analyses of the differentiated cells’ maturity for efficient cardiomyocyte differentiation. The platform was used to monitor the cardiomyocyte differentiation of iPSCs for 119 days using electrochemical impedance spectroscopy. In addition, the effect of 2D and 3D culture environments on cardiomyocyte differentiation was evaluated non-invasively by analysing the differentiated cells’ impedance. The results confirmed that more mature cardiomyocytes were produced in a 3D environment.
Gao et al. [120] decribed a microelectrode array-based sensing platform that monitors neuronal differentiation by electrochemically detecting neurotransmitters released from olfactory bulb neurons. The olfactory bulb neurons were cultured in a microelectrode array located on the corresponding platform; cells were stimulated using glutamate and gamma-aminobutyric acid (GABA) to detect electrochemical signals from the cells. As a result of detecting cells at various concentrations of glutamate and GABA, it was confirmed that cell signals depended on the concentration of the stimulant and that neurotoxicity occurred at high concentrations. The sensing ability of the platform to detect neurotransmitters through GABA stimulation can be used to detect neural differentiation of stem cells non-invasively and label-free.
Similarly, a sensing platform capable of electrochemically analysing DA exocytosis in dopaminergic neurons differentiated from human ESCs was developed in 2020 [121]. The microelectrode array in the platform was composed of reduced GO and poly(3,4-ethylene dioxythiophene):polystyrene sulfonate (PEDOT:PSS) nanocomposites. Due to the nanocomposites’ excellent electrochemical properties, the device’s LOD for DA was calculated to be 2 nM. Moreover, it could detect DA released from neurons in a location-by-amperometric manner thanks to the intrinsic advantage of the microelectrode array (Figure 6). The platform’s superior dopaminergic sensing ability allowed dopaminergic differentiation to be detected in real-time.
A review of the current literature supports that microelectrode arrays have several advantages as electrochemical sensors. First, the 3D regularly arranged electrodes could considerably improve existing electrodes’ electrochemical sensing ability by increasing the electrochemically active area. Second, the microelectrode array can be used as a stem cell cultivation platform to analyse cells on a single substrate by location. In addition, single cells and spheroids can be effectively detected.

3. Optical Sensors

3.1. Gold and Silver Nanoparticle-Based Optical Sensors

Nanomaterials, such as AuNPs and AgNPs, have excellent optical properties [122], which are unique depending on their particle size [123,124]. In addition, AuNPs can be modified through chemical conjugation with various other nanomaterials and probes to form new types of hybrid nanomaterials; this allows sensors with higher selectivity and sensitivity to target analytes to be developed [125,126]. In particular, AuNPs can greatly enhance the surface plasmon effect because they are mainly applied to optical sensing Raman spectroscopy methods [127].
Various AuNP-based optical sensors capable of monitoring stem cell differentiation non-invasively and in real-time have been reported. For example, Cao et al. report a gold-based surface-enhanced Raman spectroscopy (SERS) sensor for monitoring osteogenic differentiation [128]. This sensor had a hybrid structure based on AuNPs and nucleic acids and sensitively detectable micro-RNAs (miRs), such as miR-144-3p, associated with osteogenesis. The DNA nucleic acid binds site-specific targets via its complementary interaction. Therefore, hybrid nanostructures in which a specific DNA strand is conjugated on the surface of AuNPs are highly selective. Furthermore, the gold-based nanostructures selectively detected the Raman signals from the target miR. In addition, the probe showed high optical properties and enhanced Raman signals. These advantageous features allowed the sensor to be used in stem cell cultivation and long-term monitoring of their osteogenic differentiation.
In another study, Sun et al. developed a smart gold nanoprobe for detecting alkaline phosphatase (ALP) activity during bone marrow MSCs’ osteogenic differentiation [129]. The smart nanoprobe was designed by decorating the surface of AuNPs with 5-bromo-4-chloro-3-indolyl phosphate (Au@BCIP), which is suitable for use as a SERS nanoprobe. This probe allowed non-invasive and living-cell permeable monitoring of ALP activity with high sensitivity and selectivity. Moreover, this probe could detect a single cell without cell deformation, and the preparation process was simple, so time and effort could be saved compared to conventional methods. Therefore, the non-invasive detection of ALP activity associated with bone disease in vivo models and osteogenic differentiation of bone marrow MSCs can be more fully understood from the perspective of ALP activity.
A 2021 article by Hua et al. describes the development of an imaging probe consisting of gold nanostars (AuStar) and silver sulphide quantum dots for labelling and accurately tracking MSCs in a hypodermic and myocardial infarction model with deep tissue penetration [130] (Figure 7). The probe’s AuStar-disseminated tumour cell cluster section enabled high-resolution Raman imaging, effectively delineating stem cells in surrounding normal tissues at a single-cell resolution scale. In addition, the labelling agents were biocompatible and did not alter the MSCs’ biological properties, compensating for existing invasive monitoring methods used for tracking stem cells’ shortcomings.
Lee et al. [131] fabricated magneto-plasmonic nanorods that detected the expression level of miRNA-124 and characterised the neurogenesis of human-iPSC-derived hNSCs in a non-destructive and efficient way. The plasmonic (gold) parts of the nanorod selectively and sensitively recognised target exosomal miRNAs using a molecular beacon (MB), which was on the gold component. The MB and miRNA hybridised to form an MB–miRNA complex with an increased fluorescence signal, increasing the signal-to-noise ratio through the metal-enhanced fluorescence effect. This system was non-destructive and could possibly advance the transplantation of differentiated stem cells.
An ultrasensitive nanosensor consisting of a Au-coated nanopore thin film was reported by Yang et al. in 2021 [132]. This nanosensor was developed for the detection of N27 cells’ Glial cell-derived neurotrophic factor (GDNF) secretion [132]. The GDNF is a small protein that strongly promotes the survival of dopaminergic and motor neurons, and the evaluation of its magnetic stimulation is valuable. Due to the characteristics of gold, the nanosensor’s conversion signal appeared as an optical signal (optical interference fringes) reflected from the nanopore thin film. The optical signal shift occurred because of changes in the effective optical thickness when the GDNF bound to its antibody. The nanostructure helped coat more gold, greatly increasing the sensor’s sensitivity; this was demonstrated by a significantly improved GDNF LOD (2 pg/mL) compared with the rat ELISA kit assay (32 pg/mL). In addition, it was inexpensive, easy to use, and suitable for measuring GDNF secretion with ultra-high sensitivity. Furthermore, it can potentially be used for other highly secreted substances.
In a study on AgNP-based optical sensors, Koh et al. [133] developed a 3D cell culture scaffold and SERS-based biosensor to detect multiple differentiated markers from adipose-derived MSCs. Scaffolds were composed of electrospun nanofibres with hydrogel patterns. Moreover, the sensing scaffolds were coated with AgNPs, which can be conjugated with specific antibodies for SERS analysis. This type of scaffold culture platform successfully supported adipose-derived MSCs’ proliferation and differentiation in osteogenic differentiation media. In addition, the SERS-capture substrate detected various differentiation markers with SERS tags made of Au-Ag alloy nanoboxes. The time-dependent release of three different osteogenic differentiation markers (ALP, osteocalcin, and fibronectin) were detected up to the pg/mL levels without interference or crosstalk for three weeks. Therefore, the platform was sufficiently sensitive to monitor markers during osteogenic differentiation. This platform was suggested to overcome the limitations of existing stem cell differentiation monitoring methods, as it did not require cell pre-processing, enabled continuous analysis with a single platform, and the multi-sensing scaffold could detect various biomarkers.
Similarly, Li et al. [134] developed a SERS sensor for accurate and quantitative detection of DA in blood. The sensor consisted of zipper-like ortho-nanodimers and AgNPs with a uniform 1 nm gap. The AgNPs were electrostatically self-assembled onto a glass slide; then, the complementary DNA of the DA aptamer was bound to the surface of the AgNPs. The SERS probe was synthesised by decorating AgNPs with DA aptamers and the Raman reporter 5,5’-dithiobis-(2-nitrobenzoic acid). When these SERS probes were added to a substrate, they combined with the complementary DNA forming zipper-like ortho nanodimers with a 1 nm gap between the probe and AgNPs on the substrate in a state of equilibrium between electrostatic repulsive force and hybridisation contractility. The uniform gap allowed the SERS sensors to detect DA with ultra-high sensitivity (LOD = 10 aM) while maintaining signal uniformity (relative standard deviation < 5%). Even in a complex serum environment, the sensor maintained excellent validity and stability from 1 pM to 10 nM, which was about two times lower than conventional methods. In addition, monitoring the DA of cells released from living neurons was performed for the first time. This was achieved by introducing a single microfluidic chip containing a 3D cell culture device. The DA quantification in human blood samples showed recoveries ranging from 87.5% to 123.7%. Given the difficulty of DA quantification in complex physiological samples, this SERS sensor may provide a powerful tool for the in vitro investigation of neurological processes and clinical examination of dopaminergic disorders.
Based on the literature reviewed, gold- and silver nanomaterials have excellent optical properties and the advantage of being easily transformable into various 3D nanostructures. In addition, AuNPs can be widely applied to optical sensing methods because of their easy surface modification with other nanomaterials.

3.2. Upconversion Nanoparticle-Based Optical Sensors

Upconversion refers to a phenomenon in which external energy is changed into higher energy through a phosphor [135]. Considering that UCNPs show unique optical properties different from conventional phosphors, they have been applied to bioimaging and the optical applications of conventional phosphors. Specifically, UCNPs do not quench and are chemically stable. Furthermore, unlike conventional quantum dots, the maximum emission wavelength does not depend on particle size. In addition, UCNPs can easily emit multi-colour emissions by changing doping materials. In particular, UCNPs doped with lanthanum elements are excited by long wavelengths and have very low cytotoxicity; therefore, they are very useful for use in cell-based sensors [136]. To date, various UCNP-based sensors capable of monitoring stem cell differentiation have been reported in the literature.
For example, Wang et al. [137] developed a multifunctional UCNP capable of real-time detection and control of osteogenic differentiation in MSCs using NIR. The researchers synthesised thulium/erbium-doped core-shell UCNPs coated with mesoporous silica for drug loading and to install photomechanical azobenzene that acted as an agitator. Then, the RGD peptide and matrix metalloproteinase 13 (MMP13) sensitive peptide-black hole quencher-3 group were conjugated to the UCNP surface responsible for cell targeting and detecting differentiation. Finally, icariin, a drug that can induce MSCs’ osteogenic differentiation, was loaded onto the UCNPs to form a nanocomplex. The drug was released from the fabricated UCNP nanocomplexes using NIR light in a controlled way, which was based on trans-azobenzene being converted to a cis isomer under UV and visible light. According to the results of reverse transcription (RT)-PCR, WB, and autonomously replicating sequence (ARS), the UCNP nanocomplex efficiently induced osteogenic differentiation of MSCs under NIR light at a wavelength of 980 nm and successfully detected MMP13 produced by osteogenesis. Therefore, this developed multifunctional UCNP could control the osteogenesis of MSCs and detect cell differentiation in real time, making it a potential tool for progressing regenerative medicine.
Similarly, Yan et al. [138] reported on the controlled osteogenic differentiation of MSCs with a light-responsive nanoplatform to treat osteoporosis (OP). The nanoplatform was a modification of that of Wang et al. described previously. Like Wang et al.’s method, the UCNPs were first doped with thulium/erbium and coated with mesoporous silica. Then photocaged linker 4-(hydroxymethyl)-3-nitrobenzoic acid and polyethylene glycol linker were linked to the surface to conjugate to the cap β-cyclodextrin and the RGD-targeted peptide/MMP13-sensitive peptide-black hole quencher, creating a drug loading nanoplatform. According to the RT-PCR, WB, ALP/ARS/immunofluorescence staining, and ALP activity results, the release of icariin by NIR light at 980 nm induced controlled osteogenic differentiation of MSCs for OP treatment. In addition, MMP13 produced by the MSCs’ osteogenic differentiation cleaved the MMP13-sensitive peptide, removing the peptide-black hole quencher and allowing the UCNPs to fluoresce; this allowed real-time detection of osteogenic differentiation. The results of haematoxylin and eosin, Masson’s trichrome, immunohistochemical, tartrate-resistant acid phosphatase, and toluidine blue staining of a femoral terminal section showed that significant bone remodelling had occurred in the OP rat model. This study’s results suggested that the synthesised UCNP nanoplatform enabled remote control and real-time detection of osteogenic differentiation for OP treatment by NIR and could be a potential alternative to current OP treatment.
Non-destructive stem cell differentiation control and monitoring using UCNPs has also been studied for neural differentiation from MSCs. However, conventional UCNPs have shortcomings, such as low emission intensity due to undesirable energy transfer paths. Low power density excitations can minimise detrimental energy reverse transitions and produce bright visible emissions. Therefore, Rabie et al. [139] developed a core–shell–shell sandwich-structured UCNP with enhanced luminescent output relative to conventional UCNPs. This core–shell–shell UCNP was then used to construct a biosensor to detect DA released from stell cell-derived dopaminergic neurons (Figure 8). This UCNP detected DA released in vivo during the differentiation of stem cells into specific neurons at the single cell level in a highly selective, real-time, and non-invasive manner, with a sensitivity of at least three times higher than similarly designed systems. This sensor was demonstrated to detect DA at low concentrations. The developed NIR-based neurotransmitter detection method has significant potential for the diagnosis of diseases related to neurodegenerative diseases and stem cell treatment strategies.
The literature identified several UCNPs with high optical properties and low cytotoxicity. Moreover, UCNP-based sensors can monitor stem cell differentiation in real-time, non-invasively, without a label. In addition to cell imaging, UCNPs are potential drug delivery systems to control stem cell differentiation.

3.3. Autofluorescence-Based Optical Sensors

Various biomaterials derived from cellular organisms have autofluorescence properties, which allows them the potential to be used in biosensors for invasive and label-free sensing to obtain information about cells and tissues [140]. Furthermore, autofluorescence techniques do not require treatment or fixing of specimens and can be performed in real-time. In addition, autofluorescence-based sensors can be applied to monitor stem cell differentiation with invasive optical sensing methods, such as Raman spectroscopy and NIR, because autofluorescence can indicate a specific cellular component [141,142]. Raman-based sensing applied with autofluorescence is especially advantageous to analyse information about intracellular dynamics, which can be utilised to investigate the intracellular changes during stem cell differentiation [103].
A label-free autofluorescence-based imaging system combining optical metabolic modelling with quantitative image analysis was developed by Qian et al. [143] for monitoring human PSC (hPSC) differentiation into cardiomyocytes (Figure 9). This study was based on the fact that hPSC-derived cardiomyocytes undergo significant metabolic changes during differentiation. Specifically, the amount or ratio of oxidised flavin adenine dinucleotide (FAD) and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H), both autofluorescence metabolic materials, is influenced by the cellular conditions and differentiation and can be imaged to collect metabolic information at the single cell level. Furthermore, the ratio of NAD(P)H to FAD provides information about the relative oxidative state of the cells. Therefore, cardiomyocytes differentiated from different hPSC lines were visualised with NAD(P)H and FAD autofluorescence probes. According to the autofluorescence imaging on the eighth day, the intensity of NAD(P)H autofluorescence differed depending on the differentiation efficiencies. In addition, the cardiomyocytes and non-cardiomyocytes showed different autofluorescence intensities. For instance, NAD(P)H and FAD fluorescence after 8 days was exhibited in 84.1% of the differentiated cells, compared with 0.3% in undifferentiated cells.
In another study, Suhito et al. [144] reported on an autofluorescence-integrated Raman mapping analysis for label-free monitoring of adipogenic differentiation. Raman mapping analysis has the critical issue of long detection time, which results in cell apoptosis. To address this issue, these researchers developed a novel optical sensing method that enabled the rapid and non-destructive analysis of adipogenesis. The authors confirmed that the lipid droplets present in adipocytes were identified with the developed autofluorescence-integrated Raman sensing method; the Raman scattering of lipid droplets was aroused at 2850–2855 cm−1. In addition, this method was utilised in the large-scale sensing analysis of multiple cells in culture plates by obtaining Raman mapping images at low magnification. Moreover, the analysis required a very short time (<20 min) and could scan 440 × 330 μm area per mapping image. Furthermore, the authors analysed in-batch and batch-to-batch variations of adipogenic differentiation throughout the autofluorescence-Raman imaging.
Similarly, Li et al. showed a label-free autofluorescence sensing system capable of monitoring of neurogenesis [145]. The optical sensor was based on tetrapod-shaped ZnO (t-ZnO) microparticles capable of label-free monitoring of neuronal differentiation. Specifically, this sensor formed 3D scaffolds that analysed DA released from neurons embedded on the surface using autofluorescence imaging. Interestingly, t-ZnO nanoparticles with four hexagonal arms were biocompatible and autofluorescence materials that fluoresced under UV light because they contained anion vacancies. The nanoparticles’ autofluorescence was demonstrated to be very sensitive to hole scavengers, which was used for quantitative DA analysis. Furthermore, nanoparticles’ autofluorescence acted as a quencher for the autofluorescence of the t-ZnO nanoparticles. Due to its 3D structures with high surface area and autofluorescence, the t-ZnO nanoparticles-based sensor showed a high sensing performance toward DA (LOD: 0.137 μM). Furthermore, DA was selectively datable in the presence of interfering molecules, including citric acid, glutamine, ascorbic acid, glucose, KCl and calcium chloride.
Autofluorescence-based optical sensing techniques were reported as suitable for non-invasive, non-destructive, and label-free monitoring of stem cell differentiation. Chronic lymphocytic leukaemia-derived autofluorescence could be utilised to analyse the biological changes in stem cell differentiation. Furthermore, most autofluorescence is biocompatible, which allows stem cells to be stably cultured and differentiated on the sensor for long time periods.

4. Conclusions and Future Perspectives

This review summarised recent progress in nano-biosensors for non-invasively monitoring of stem cell differentiation. Various nano- and micromaterials, such as AuNPs, AgNPs, UCNPs, autofluorescence probes, nucleic acids, microfluidic systems and microelectrode arrays, were reviewed and compared. Furthermore, their advantageous use to improve the biosensors’ performance, including sensitivity and selectivity, for monitoring stem cell differentiation was appraised. In the case of electrochemical sensors, the electrochemically active surface area was found to be a crucial parameter; this is because the redox reaction of target analytes occurs on the electrode surface via electron transfer. Moreover, various nanomaterials were identified that could be applied to improve the electrochemically active surface. Furthermore, specific micro-scaled systems were identified that could be utilised to enhance the advantage of existing nanomaterials, providing more sensitive and selective sensing capabilities toward target molecules. The literature scrutinised supported that many nanomaterials have been applied in optical sensing to enhance the optical signal intensity to target analytes specifically or to make the analysis process simpler and faster. In addition to excellent sensing capabilities, various nano-biosensors have functioned as stem cell cultivation platforms by providing cell-friendly surfaces. In conclusion, electrochemical or optical nano-biosensors capable of monitoring stem cell differentiation in a non-invasive, non-destructive, and label-free sensing system could be used to control stem cell differentiation and develop practical and efficient stem cell therapies.
Table 1. Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation.
Table 1. Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation.
MethodMaterial and
Technique
AdvantagesLimitationsTarget/SensitivityDifferentiationRef.
Electrochemical
sensing
AuNPs
High biocompatibility towards hESC growth and adhesion
Label-free identification of differentiated cells
Insufficient sensitivity
Cells/12,500 cellsEpithelial differentiation[59]
AuNPs-nanoarray
Non-destructive and real-time sensing system for monitoring of osteogenic differentiation
Providing topographical cues favourable for stem cell differentiation
Low sensing performance at early differentiation stages
ALP/0.03 unit/mLOsteogenic differentiation[73]
AuNPs-RGD-Fe3O4
Capable of regulation of mechanotransduction-mediated stem cell differentiation
In-situ time-resolved monitoring of osteogenic differentiation
Difficult analysis of early differentiation
ALP/-Osteogenic differentiation[74]
AuNPs
Simultaneous electrochemical monitoring and kidney organoid generation on-a-chip
Electrical signal interpretation in multiple detection of kidney
organoid on-a-chip
Difficult to identify detailed cell subtypes
Cells/21,363 cellsKidney organoids[75]
Aptamer-CPNTs
Highly sensitive and selective detection of DA
Non-destructive monitoring of exocytotic DA release from living neurons
Potential colouration effect and its poor stability
DA/100 pMNeuronal differentiation[89]
Peptide-Oligonucleotide
Non-destructive detection of cardiomyogenic differentiation
Applicable to label-free drug screening
Insufficient selectivity for applications in cell culture environments
cTnI/0.42 pg/mLCardiomyocyte differentiation[90]
Aptamer-Pdots-microarray
High throughput DA sensing at the single cell level
Imaging of exocytotic DA release from living neurons
High variations in DA signals
DA/53 pMNeuronal differentiation[91]
Aptamer
Based on a nanostructure suitable for excluding non-specific proteins as interfering molecules
Suitable to track in situ neurochemical flux in the complex cell media
Difficult sensor operation
5-HT/< 1 nMNeuronal differentiation[92]
Graphene-
Simultaneously detection of DA and serotonin
Potential for multi-site neurotransmitter mapping with high spatial and temporal resolution
Platform not proven applicable to cell culture
DA/61.67 nMNeuronal differentiation[104]
Pyrolytic carbon fibre
Real-time monitoring of exocytotic DA release
Multifunctional platform applicable to stem cell-based sensing and therapeutics
Insufficiently proven sensor selectivity
DA/-Neuronal differentiation[105]
Carbon nanotube
Label-free and non-invasive evaluation of antipsychotic drugs on DA release from neuronal cells
Insufficient selectivity toward DA
DA/<10 nMNeuronal differentiation[106]
Microfluidics
Label-free and non-invasive impedance measurements of single cells
Insufficient for practical applications in terms of throughput
-Osteogenic differentiation[113]
Compartmentalised the neuronal culture into three distinct but axonally connected networks
Mimicking local and circuitry functionality of brain tissue
Includes complicated devices and procedures
-Neuronal differentiation[114]
Non-invasive monitoring of cell-secreted multiple biomarkers in response to chemotherapeutic drugs
Contains 3D cardiac and BC spheroid-based microtissues with mechanical properties mimicking individual native tissues
Short-term (<6 days) analysis of differentiation
Troponin T and HER-2/<0.1 pg/mLCardiomyocyte differentiation[115]
Microelectrode array
Long-term (>100 days) monitoring of cardiomyocyte differentiation with 3D cultivation system
Signal variations during monitoring differentiation
E4031/<1 nMCardiomyocyte differentiation[119]
In vitro multi-site and long-term monitoring of bioelectrical activity changes in the neuronal network
Cross-correlation analysis between channels capable of evaluating the connection status in the neuronal networks
Insufficient biological validation
Glutamate and GABA/100 nM and 50 nM, respectivelyNeuronal differentiation[120]
Microelectrode array-rGO
Stable monitoring of neuronal differentiation from long-term cultured neurons
Quantitative analysis of different types of DA vesicular exocytosis
Insufficient selectivity toward DA
DA/2 nMNeuronal differentiation[121]
Optical sensingAuNPs-DNA
Long-term (>21 d) sensing of biomarkers involved in osteogenic differentiation
Label-free monitoring of osteogenic differentiation
Potential side effects of cellular uptake of AuNPs
miR-144-3p/13.6 aMOsteogenic differentiation[128]
AuNPs-BCIP
Label-free monitoring of osteogenic differentiation
Potential side effects of cellular uptake of AuNPs
ALP/1.0 U/LOsteogenic differentiation[129]
AuStar-DTCC-Ag2S
Depth-independent and high-resolution stem cell-tracking strategy
Real-time sensing of in vivo functionality of stem cells
Potential side effects of cellular uptake of AuNPs
Cells/<100 cellsAdipogenic differentiation
Osteogenic differentiation
Chondrogenic differentiation
[130]
Au-Ni nanorods
Highly selective detection of stem cell differentiation
Applicable to in vitro and in vivo stem cell differentiation modulation
Potentially undesired effects of magnetic fields on cell behaviour
miR-124/<1 pMNeuronal differentiation[131]
AuNPs-nanopore
Cost-effective and sensitive sensing method for detection of neuronal differentiation
Signal variations during monitoring differentiation
GDNF/<2 pg/mLNeuronal differentiation[132]
AgNPs
Label-free sensing system for sensing multiple osteogenic differentiation-involved markers.
3D culture system integrated-sensing system
Signal variations during monitoring differentiation
ALP, OC, and FN/-Osteogenic differentiation[133]
AgNPs-Aptamer
Ultrasensitive and reliable detection of exocytotic DA release from living neurons
3D culture system integrated-sensing system
Insufficient biological validation
DA/10 aM in PBS and 10 fM in serumNeuronal differentiation[135]
UCNP
Simultaneous differentiation control and sensing of osteogenic differentiation
Label-free detection of osteogenic differentiation
Potential cytotoxicity by photothermal effect
MMP13/-Osteogenic differentiation[137]
Simultaneous differentiation control and sensing of osteogenic differentiation
Applicable to in vitro and in vivo stem cell differentiation modulation
Potential cytotoxicity by photothermal effect
MMP13/-Osteogenic differentiation[138]
Monitoring of neuronal differentiation at single-cell level
Real-time analysis of the function of DAnergic neurons
Potential cytotoxicity by photothermal effect
DA/<1 pMNeuronal differentiation[140]
Autofluorescence
Label-free monitoring of cardiomyocyte differentiation
Can predict the cardiomyocyte differentiation efficiency early in the differentiation process
Potential phototoxicity during imaging procedures
FAD and NAD(P)H/-Cardiomyocyte differentiation[143]
Non-destructive and large-scale analysis (440 × 330 μm area) of adipogenic differentiation
Rapid visualisation (<20 min) of the cell morphology and cytosolic microstructure
Difficult to apply to multiple-cell analysis
Lipid droplets/-Adipogenic differentiation[144]
t-ZnO
Utilisable directly without complicated probe immobilisation or modification
High resolution detection of DA release from neural tissue
Insufficient lifetime for living tissue cultivation
DA/0.137 μMNeuronal differentiation[145]
Note: 3D, three-dimensional; 5-HT, 5-hydroxytryptamine; AgNPs silver nanoparticles; Ag2S, silver sulphide; ALP, alkaline phosphatase; AuNPs, gold nanoparticles; Au-Ni, gold-nickel; AuStar, gold nanostar; BC, breast cancer; BCIP, 5-bromo-4-chloro-3-indolyl phosphate; CPNTs, carboxylated polypyrrole nanotubes; cTnI, cardiac troponin I; DA, dopamine; DAnergic neurons, dopaminergic neurons; DNA, deoxyribonucleic acid; DTCC, disseminated tumour cell clusters; E4031, N-[4-[1-[2-(6-methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]; FAD, flavin ade-nine dinucleotide; Fe3O4, iron (II, III) oxide; FN, fibronectin; GABA, γ-aminobutyric acid; GDNF, glial cell-derived neurotrophic factor; HER-2, human epidermal growth factor receptor-2; miR, microRNA; MMP13, metalloproteinase 13; NAD(P)H, nicotinamide adenine dinucleotide (phosphate); OC, osteocalcin; Pdots, polymer dots, RGD, Arg-Gly-Asp ligand; rGO, reduced graphene oxide; t-ZnO, tetrapod zinc oxide; UCNPs, upconversion nanoparticles.

Author Contributions

M.-J.K., Y.-W.C. and T.-H.K. wrote and revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Chung-Ang University Graduate Research Scholarship in 2022 and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2022R1A2C4002217).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Van der Kooy, D.; Weiss, S. Why stem cells? Science 2000, 287, 1439–1441. [Google Scholar] [CrossRef]
  2. Cho, Y.-W.; Jee, S.; Suhito, I.R.; Lee, J.-H.; Park, C.G.; Choi, K.M.; Kim, T.-H. Single metal-organic framework–embedded nanopit arrays: A new way to control neural stem cell differentiation. Sci. Adv. 2022, 8, eabj7736. [Google Scholar] [CrossRef]
  3. Slavin, S.; Nagler, A.; Naparstek, E.; Kapelushnik, Y.; Aker, M.; Cividalli, G.; Varadi, G.; Kirschbaum, M.; Ackerstein, A.; Samuel, S.; et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 1998, 91, 756–763. [Google Scholar] [CrossRef]
  4. Kim, S.U.; De Vellis, J. Stem cell-based cell therapy in neurological diseases: A review. J. Neurosci. Res. 2009, 87, 2183–2200. [Google Scholar] [CrossRef]
  5. Haas, S.; Weidner, N.; Winkler, J. Adult stem cell therapy in stroke. Curr. Opin. Neurol. 2005, 18, 59–64. [Google Scholar] [CrossRef]
  6. Asahara, T.; Kalka, C.; Isner, J.M. Stem cell therapy and gene transfer for regeneration. Gene Ther. 2000, 7, 451–457. [Google Scholar] [CrossRef]
  7. Zakrzewski, W.; Dobrzyński, M.; Szymonowicz, M.; Rybak, Z. Stem cells: Past, present, and future. Stem Cell Res. Ther. 2019, 10, 68. [Google Scholar] [CrossRef]
  8. Golchin, A.; Farahany, T.Z. Biological products: Cellular therapy and FDA approved products. Stem Cell Rev. Rep. 2019, 15, 166–175. [Google Scholar] [CrossRef]
  9. Müller, A.M.; Huppertz, S.; Henschler, R. Hematopoietic stem cells in regenerative medicine: Astray or on the path? Transfus. Med. Hemotherapy 2016, 43, 247–254. [Google Scholar] [CrossRef]
  10. Mosaad, Y.M. Hematopoietic stem cells: An overview. Transfus. Apher. Sci. 2014, 51, 68–82. [Google Scholar] [CrossRef]
  11. Herberts, C.A.; Kwa, M.S.; Hermsen, H.P. Risk factors in the development of stem cell therapy. J. Transl. Med. 2011, 9, 29. [Google Scholar] [CrossRef]
  12. Trounson, A.; McDonald, C. Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell 2015, 17, 11–22. [Google Scholar] [CrossRef]
  13. Kang, S.K.; Shin, I.S.; Ko, M.S.; Jo, J.Y.; Ra, J.C. Journey of mesenchymal stem cells for homing: Strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012, 2012, 342968. [Google Scholar] [CrossRef]
  14. Mastri, M.; Lin, H.; Lee, T. Enhancing the efficacy of mesenchymal stem cell therapy. World J. Stem Cells 2014, 6, 82–93. [Google Scholar] [CrossRef]
  15. Cho, Y.-W.; Kim, D.-S.; Suhito, I.R.; Han, D.K.; Lee, T.; Kim, T.-H. Enhancing neurogenesis of neural stem cells using homogeneous nanohole pattern-modified conductive platform. Int. J. Mol. Sci. 2019, 21, 191. [Google Scholar] [CrossRef]
  16. Lee, S.H.; Jeon, S.; Qu, X.; Kang, M.S.; Lee, J.H.; Han, D.-W.; Hong, S.W. Ternary MXene-loaded PLCL/collagen nanofibrous scaffolds that promote spontaneous osteogenic differentiation. Nano Converg. 2022, 9, 38. [Google Scholar] [CrossRef]
  17. VanGuilder, H.D.; Vrana, K.E.; Freeman, W.M. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008, 44, 619–626. [Google Scholar] [CrossRef]
  18. Tokuyasu, K.T. Application of cryoultramicrotomy to immunocytochemistry. J. Microsc. 1986, 143, 139–149. [Google Scholar] [CrossRef]
  19. Adan, A.; Alizada, G.; Kiraz, Y.; Baran, Y.; Nalbant, A. Flow cytometry: Basic principles and applications. Crit. Rev. Biotechnol. 2016, 37, 163–176. [Google Scholar] [CrossRef]
  20. Mahmood, T.; Yang, P.C. Western blot: Technique, theory, and trouble shooting. N. Am. J. Med. Sci. 2012, 4, 429–434. [Google Scholar] [CrossRef]
  21. Enzmann, G.U.; Benton, R.L.; Talbott, J.F.; Cao, Q.; Whittemore, S.R.; Zhang, Y.; Yang, J.; Zhang, P.; Liu, T.; Xu, J.; et al. Functional considerations of stem cell transplantation therapy for spinal cord repair. J. Neurotrauma 2006, 23, 479–495. [Google Scholar] [CrossRef]
  22. Bonanos, N.; Steel, B.C.H.; Butler, E.P.; Macdonald, J.R.; Johnson, W.B.; Worrell, W.L.; Niklasson, G.A.; Malmgren, S.; Strømme, M.; Sundaram, S.K.; et al. Applications of Impedance Spectroscopy. In Impedance Spectrophotometry: Theory, Experiment, and Applications, 3rd ed.; Barsoukov, E., Macdonald, J.R., Eds.; John Wiley and Sons Inc.: Hoboken, NJ, USA, 2018; pp. 175–478. [Google Scholar] [CrossRef]
  23. Katz, E.; Willner, I. Probing biomolecular interactions at conductive and semiconductive surfaces by impedance spectroscopy: Routes to impedimetric immunosensors, DNA-sensors, and enzyme biosensors. Electroanalysis 2003, 15, 913–947. [Google Scholar] [CrossRef]
  24. Notingher, I.J. Raman spectroscopy cell-based biosensors. Sensors 2007, 7, 1343–1358. [Google Scholar] [CrossRef]
  25. Shafer-Peltier, K.E.; Haynes, C.L.; Glucksberg, M.R.; Van Duyne, R.P. Toward a glucose biosensor based on surface-enhanced Raman scattering. J. Am. Chem. Soc. 2003, 125, 588–593. [Google Scholar] [CrossRef] [PubMed]
  26. Zhang, Y.; Sun, J.; Liu, L.; Qiao, H. A review of biosensor technology and algorithms for glucose monitoring. J. Diabetes Complicat. 2021, 35, 107929. [Google Scholar] [CrossRef] [PubMed]
  27. Wu, Y.; Ray, A.; Wei, Q.; Feizi, A.; Tong, X.; Chen, E.; Luo, Y.; Ozcan, A. Deep learning enables high-throughput analysis of particle-aggregation-based biosensors imaged using holography. ACS Photon 2019, 6, 294–301. [Google Scholar] [CrossRef]
  28. Skládal, P. Advances in electrochemical immunosensors. Electroanalysis 1997, 9, 737–745. [Google Scholar] [CrossRef]
  29. Felix, F.S.; Angnes, L. Electrochemical immunosensors—A powerful tool for analytical applications. Biosens. Bioelectron. 2018, 102, 470–478. [Google Scholar] [CrossRef]
  30. Wu, Z.; Hu, J.; Zeng, T.; Zhang, Z.-L.; Chen, J.; Wong, G.; Qiu, X.; Liu, W.; Gao, G.F.; Bi, Y.; et al. Ultrasensitive Ebola virus detection based on electroluminescent nanospheres and immunomagnetic separation. Anal. Chem. 2017, 89, 2039–2048. [Google Scholar] [CrossRef]
  31. Chen, D.; Zhang, M.; Zhou, F.; Hai, H.; Li, J. Ultrasensitive electroluminescence biosensor for a breast cancer marker microRNA based on target cyclic regeneration and multi-labeled magnetized nanoparticles. Microchim. Acta 2019, 186, 628. [Google Scholar] [CrossRef]
  32. Roh, J.; Cho, Y.H.; Ahn, D.J. Sustainable colorimetric/luminescent sensors enabled by armored lipid nanoparticles. Nano Converg. 2022, 9, 42. [Google Scholar] [CrossRef]
  33. Kweon, S.Y.; Park, J.P.; Park, C.Y.; Park, T.J. Graphene oxide-mediated fluorometric aptasensor for okadaic acid detection. BioChip J. 2022, 16, 207–213. [Google Scholar] [CrossRef]
  34. Ronkainen, N.J.; Halsall, H.B.; Heineman, W.R. Electrochemical biosensors. Chem. Soc. Rev. 2010, 39, 1747–1763. [Google Scholar] [CrossRef] [PubMed]
  35. Hammond, J.L.; Formisano, N.; Estrela, P.; Carrara, S.; Tkac, J. Electrochemical biosensors and nanobiosensors. Essays Biochem. 2016, 60, 69–80. [Google Scholar] [CrossRef]
  36. Pohanka, M.; Skládal, P. Electrochemical biosensors—Principles and applications. J. Appl. Biomed. 2008, 6, 57–64. [Google Scholar] [CrossRef]
  37. Jothimani, G.; Pathak, S.; Dutta, S.; Duttaroy, A.K.; Banerjee, A. A comprehensive cancer-associated microRNA expression profiling and proteomic analysis of human umbilical cord mesenchymal stem cell-derived exosomes. Tissue Eng. Regen. Med. 2022, 19, 1013–1031. [Google Scholar] [CrossRef]
  38. Serafin, A.; Rubio, M.C.; Carsi, M.; Ortiz-Serna, P.; Sanchis, M.J.; Garg, A.K.; Oliveira, J.M.; Koffler, J.; Collins, M.N. Electroconductive PEDOT nanoparticle integrated scaffolds for spinal cord tissue repair. Biomater. Res. 2022, 26, 63. [Google Scholar] [CrossRef]
  39. Azmi, N.E.; Rashid, A.H.A.; Abdullah, J.; Yusof, N.A.; Sidek, H. Fluorescence biosensor based on encapsulated quantum dots/enzymes/sol-gel for non-invasive detection of uric acid. J. Lumin 2018, 202, 309–315. [Google Scholar] [CrossRef]
  40. Bantz, K.C.; Meyer, A.F.; Wittenberg, N.J.; Im, H.; Kurtuluş, O.; Lee, S.H.; Lindquist, N.C.; Oh, S.-H.; Haynes, C.L. Recent progress in SERS biosensing. Phys. Chem. Chem. Phys. 2011, 13, 11551–11567. [Google Scholar] [CrossRef]
  41. Rachim, V.P.; Chung, W.-Y. Wearable-band type visible-near infrared optical biosensor for non-invasive blood glucose monitoring. Sens. Actuators B Chem. 2019, 286, 173–180. [Google Scholar] [CrossRef]
  42. Eom, G.; Hang, A.; Kim, H.; Moon, J.; Kang, H.; Jung, J.; Lim, E.-K.; Jepng, J.; Park, H.G.; Kang, T. Ultrasensitive detection of ovarian cancer biomarker using Au nanoplate SERS immunoassay. BioChip J. 2021, 15, 348–355. [Google Scholar] [CrossRef]
  43. Kim, H.; Han, Y.; Suhito, I.R.; Choi, Y.; Kwon, M.; Son, H.; Kim, H.-R.; Kim, T.-H. Raman spectroscopy-based 3D analysis of odontogenic differentiation of human dental pulp stem cell spheroids. Anal. Chem. 2021, 93, 9995–10004. [Google Scholar] [CrossRef] [PubMed]
  44. Suhito, I.R.; Angeline, N.; Lee, K.-H.; Kim, H.; Park, C.G.; Luo, Z.; Kim, T.-H. A spheroid-forming hybrid gold nanostructure platform that electrochemically detects anticancer effects of curcumin in a multicellular brain cancer Model. Small 2021, 17, 2002436. [Google Scholar] [CrossRef] [PubMed]
  45. Tenney, R.M.; Discher, D.E. Stem cells, microenvironment mechanics, and growth factor activation. Curr. Opin. Cell Biol. 2009, 21, 630–635. [Google Scholar] [CrossRef]
  46. Pandey, P.; Datta, M.; Malhotra, B.D. Prospects of nanomaterials in biosensors. Anal. Lett. 2008, 41, 159–209. [Google Scholar] [CrossRef]
  47. Naveen, M.H.; Gurudatt, N.G.; Shim, Y.-B. Applications of conducting polymer composites to electrochemical sensors: A review. Appl. Mater. Today 2017, 9, 419–433. [Google Scholar] [CrossRef]
  48. Beaver, K.; Dantanarayana, A.; Minteer, S.D. Materials approaches for improving electrochemical sensor performance. J. Phys. Chem. B 2021, 125, 11820–11834. [Google Scholar] [CrossRef]
  49. Chen, I.-J.; White, I.M. High-sensitivity electrochemical enzyme-linked assay on a microfluidic interdigitated microelectrode. Biosens. Bioelectron. 2011, 26, 4375–4381. [Google Scholar] [CrossRef]
  50. Shin, S.R.; Zhang, Y.S.; Kim, D.J.; Manbohi, A.; Avci, H.; Silvestri, A.; Aleman, J.; Hu, N.; Kilic, T.; Keung, W.; et al. Aptamer-based microfluidic electrochemical biosensor for monitoring cell-secreted trace cardiac biomarkers. Anal. Chem. 2016, 88, 10019–10027. [Google Scholar] [CrossRef]
  51. Sage, A.T.; Besant, J.D.; Lam, B.; Sargent, E.H.; Kelley, S.O. Ultrasensitive electrochemical biomolecular detection using nanostructured microelectrodes. Acc. Chem. Res. 2014, 47, 2417–2425. [Google Scholar] [CrossRef]
  52. Toderas, F.; Baia, M.; Astilean, S. Controlling gold nanoparticle assemblies for efficient surface-enhanced Raman scattering and localized surface plasmon resonance sensors. Nanotechnology 2007, 18, 255702. [Google Scholar] [CrossRef]
  53. Nie, Y.; Jin, C.; Zhang, J.X.J. Microfluidic in situ patterning of silver nanoparticles for surface-enhanced Raman spectroscopic sensing of biomolecules. ACS Sens. 2021, 6, 2584–2592. [Google Scholar] [CrossRef] [PubMed]
  54. Widmann, K.; Ao, T.; Foord, M.E.; Price, D.F.; Ellis, A.D.; Springer, P.T.; Ng, A. Single-state measurement of electrical conductivity of warm dense gold. Phys. Rev. Lett. 2004, 92, 125002. [Google Scholar] [CrossRef]
  55. Guo, S.; Wang, E. Synthesis and electrochemical applications of gold nanoparticles. Anal. Chim. Acta 2007, 598, 181–192. [Google Scholar] [CrossRef] [PubMed]
  56. Yu, A.; Liang, Z.; Caruso, F. Nanostructured electrochemical sensor based on dense gold nanoparticle films. Nano Lett. 2003, 3, 1203–1207. [Google Scholar] [CrossRef]
  57. Luo, X.; Morrin, A.; Killard, A.J.; Smyth, M.R. Application of nanoparticles in electrochemical sensors and biosensors. Electroanalysis 2006, 18, 319–326. [Google Scholar] [CrossRef]
  58. El-Said, W.A.; Al-Bogami, A.S.; Alshitari, W.; El-Hady, D.A.; Saleh, T.S.; El-Mokhtar, M.A.; Choi, J.-W. Electrochemical microbiosensor for detecting COVID-19 in a patient sample based on gold microcuboids pattern. BioChip J. 2021, 15, 287–295. [Google Scholar] [CrossRef]
  59. Suhito, I.R.; Kang, E.-S.; Kim, D.-S.; Baek, S.; Park, S.-J.; Moon, S.-H.; Luo, Z.; Lee, D.; Min, J.; Kim, T.-H. High density gold nanostructure composites for precise electrochemical detection of human embryonic stem cells in cell mixture. Colloids Surf. B Biointerfaces 2019, 180, 384–392. [Google Scholar] [CrossRef]
  60. Kim, D.-S.; Kang, E.-S.; Baek, S.; Choo, S.-S.; Chung, Y.-H.; Lee, D.; Min, J.; Kim, T.-H. Electrochemical detection of dopamine using periodic cylindrical gold nanoelectrode arrays. Sci. Rep. 2018, 8, 14049. [Google Scholar] [CrossRef]
  61. Koo, K.-M.; Kim, C.-D.; Kim, H.; Cho, Y.-W.; Suhito, I.R.; Kim, T.-H. Extracellularly detectable electrochemical signals of living cells originate from metabolic reactions. Adv. Sci. 2023, 10, e2207084. [Google Scholar] [CrossRef]
  62. Ju, F.N.; Kim, C.-H.; Lee, K.-H.; Kim, C.-D.; Lim, J.; Lee, T.; Park, C.G.; Kim, T.-H. Gold nanostructure-integrated conductive microwell arrays for uniform cancer spheroid formation and electrochemical drug screening. Biosens. Bioelectron. 2023, 222, e115003. [Google Scholar] [CrossRef] [PubMed]
  63. Koo, K.-M.; Go, Y.-H.; Kim, S.-M.; Kim, C.-D.; Do, J.T.; Kim, T.-H.; Cha, H.-J. Label-free and non-destructive identification of naïve and primed embryonic stem cells based on differences in cellular metabolism. Biomaterials 2023, 293, e121939. [Google Scholar] [CrossRef] [PubMed]
  64. Chen, Y.; Xianyu, Y.; Jiang, X. Surface modification of gold nanoparticles with small molecules for biochemical analysis. Acc. Chem. Res. 2017, 50, 310–319. [Google Scholar] [CrossRef]
  65. Perrault, S.D.; Chan, W.C.W. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50−200 nm. J. Am. Chem. Soc. 2010, 131, 17042–17043. [Google Scholar] [CrossRef] [PubMed]
  66. Zhu, T.; Vasilev, K.; Kreiter, M.; Mittler, S.; Knoll, W. Surface modification of citrate-reduced colloidal gold nanoparticles with 2-mercaptosuccinic Acid. Langmuir 2003, 19, 9518–9525. [Google Scholar] [CrossRef]
  67. Connor, E.E.; Mwamuka, J.; Gole, A.; Murphy, C.J.; Wyatt, M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1, 325–327. [Google Scholar] [CrossRef]
  68. Baranes, K.; Shevach, M.; Shefi, O.; Dvir, T. Gold nanoparticle-decorated scaffolds promote neuronal differentiation and maturation. Nano Lett. 2016, 16, 2916–2920. [Google Scholar] [CrossRef]
  69. Yi, C.; Liu, D.; Fong, C.-C.; Zhang, J.; Yang, M. Gold nanoparticles promote osteogenic differentiation of mesenchymal stem cells through p38 MAPK pathway. ACS Nano 2010, 4, 6439–6448. [Google Scholar] [CrossRef]
  70. Ricles, L.M.; Nam, S.Y.; Sokolov, K.; Emelianov, S.Y.; Suggs, L.J. Function of mesenchymal stem cells following loading of gold nanotracers. Int. J. Nanomed. 2011, 6, 407–416. [Google Scholar] [CrossRef]
  71. Silva, A.K.A.; Di Corato, R.; Pellegrino, T.; Chat, S.; Pugliese, G.; Luciani, N.; Gazeau, F.; Wilhelm, C. Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. Nanoscale 2013, 5, 11374–11384. [Google Scholar] [CrossRef]
  72. Zong, J.; Cobb, S.L.; Cameron, N.R. Peptide-functionalized gold nanoparticles: Versatile biomaterials for diagnostic and therapeutic applications. Biomater. Sci. 2017, 5, 872–886. [Google Scholar] [CrossRef] [PubMed]
  73. Lee, J.-H.; Choi, H.K.; Yang, L.; Chueng, S.-T.D.; Choi, J.-W.; Lee, K.-B. Nondestructive real-time monitoring of enhanced stem cell differentiation using a graphene-Au hybrid nanoelectrode array. Adv. Mater. 2018, 30, e1802762. [Google Scholar] [CrossRef] [PubMed]
  74. Lee, S.; Kim, M.S.; Patel, K.D.; Choi, H.; Thangam, R.; Yoon, J.; Koo, T.M.; Jung, H.J.; Min, S.; Bae, G.; et al. Magnetic control and real-time monitoring of stem cell differentiation by the ligand nanoassembly. Small 2021, 17, e2102892. [Google Scholar] [CrossRef] [PubMed]
  75. Suhito, I.R.; Kim, J.W.; Koo, K.-M.; Nam, S.A.; Kim, Y.K.; Kim, T.-H. In situ detection of kidney organoid generation from stem cells using a simple electrochemical method. Adv. Sci. 2022, 9, e2200074. [Google Scholar] [CrossRef] [PubMed]
  76. Saleh, J.; Mercier, B.; Xi, W. Bioengineering methods for organoid systems. Biol. Cell 2021, 113, 475–491. [Google Scholar] [CrossRef]
  77. Rossi, G.; Manfrin, A.; Lutolf, M.P. Progress and potential in organoid research. Nat. Rev. Genet. 2018, 19, 671–687. [Google Scholar] [CrossRef]
  78. Huch, M.; Knoblich, J.A.; Lutolf, M.P.; Martinez-Arias, A. The hope and the hype of organoid research. Development 2017, 144, 938–941. [Google Scholar] [CrossRef]
  79. Watson, J.D.; Crick, F.H. Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid. Nature 1953, 171, 737–738. [Google Scholar] [CrossRef]
  80. Baeumner, A.J.; Pretz, J.; Fang, S. A universal nucleic acid sequence biosensor with nanomolar detection limits. Anal. Chem. 2004, 76, 888–894. [Google Scholar] [CrossRef]
  81. Wang, J. Electrochemical nucleic acid biosensors. Anal. Chim. Acta 2002, 469, 63–71. [Google Scholar] [CrossRef]
  82. Du, Y.; Dong, S. Nucleic acid biosensors: Recent advances and perspectives. Anal. Chem. 2017, 89, 189–215. [Google Scholar] [CrossRef] [PubMed]
  83. Park, G.; Lee, M.; Park, C.; Min, J.; Lee, T. Selection of DNA aptamer and its application as an electrical biosensor for Zika virus detection in human serum. Nano Converg. 2022, 9, 41. [Google Scholar] [CrossRef] [PubMed]
  84. Darmostuk, M.; Rimpelova, S.; Gbelcova, H.; Ruml, T. Current approaches in SELEX: An update to aptamer selection technology. Biotechnol. Adv. 2015, 33, 1141–1161. [Google Scholar] [CrossRef] [PubMed]
  85. Gopinath, S.C.B. Methods developed for SELEX. Anal. Bioanal. Chem. 2007, 387, 171–182. [Google Scholar] [CrossRef]
  86. Zhou, W.; Huang, P.-J.J.; Ding, J.; Liu, J. Aptamer-based biosensors for biomedical diagnostics. Anal. 2014, 139, 2627–2640. [Google Scholar] [CrossRef]
  87. Kim, Y.S.; Raston, N.H.; Gu, M.B. Aptamer-based nanobiosensors. Biosens. Bioelectron. 2016, 76, 2–19. [Google Scholar] [CrossRef]
  88. Song, S.; Wang, L.; Li, J.; Fan, C.; Zhao, J. Aptamer-based biosensors. TrAC Trends Anal. Chem. 2008, 27, 108–117. [Google Scholar] [CrossRef]
  89. Park, S.J.; Lee, J.; Seo, S.E.; Kim, K.H.; Lee, S.H.; Ban, H.S.; Lee, B.D.; Song, H.S.; Kim, J.; Lee, C.S. High-performance conducting polymer nanotube-based liquid-ion gated field-effect transistor aptasensor for dopamine exocytosis. Sci. Rep. 2020, 10, 3772. [Google Scholar] [CrossRef]
  90. Han, K.; Li, G.; Tian, L.; Li, L.; Shi, Y.; Huang, T.; Li, Y.; Xu, Q. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I. Biochem. Eng. J. 2021, 174, 108104. [Google Scholar] [CrossRef]
  91. Wang, N.; Ao, H.; Xiao, W.; Chen, W.; Li, G.; Wu, J.; Ju, H. Confined electrochemiluminescence imaging microarray for high-throughput biosensing of single cell-released dopamine. Biosens. Bioelectron. 2022, 201, 113959. [Google Scholar] [CrossRef]
  92. Nakatsuka, N.; Heard, K.J.; Faillétaz, A.; Momotenko, D.; Vörös, J.; Gage, F.H.; Vadodaria, K.C. Sensing serotonin secreted from human serotonergic neurons using aptamer-modified nanopipettes. Mol. Psychiatry 2021, 26, 2753–2763. [Google Scholar] [CrossRef] [PubMed]
  93. Hajian, A.; Lindström, S.B.; Pettersson, T.; Hamedi, M.M.; Wågberg, L. Understanding the dispersive action of nanocellulose for carbon nanomaterials. Nano Lett. 2017, 17, 1439–1447. [Google Scholar] [CrossRef] [PubMed]
  94. Teradal, N.L.; Jelinek, R. Carbon nanomaterials in biological studies and biomedicine. Adv. Healthc. Mater. 2017, 6, 1700574. [Google Scholar] [CrossRef] [PubMed]
  95. Choi, H.K.; Kim, C.-H.; Lee, S.N.; Kim, T.-H.; Oh, B.-K. Nano-sized graphene oxide coated nanopillars on microgroove polymer arrays that enhance skeletal muscle cell differentiation. Nano Converg. 2021, 8, 40. [Google Scholar] [CrossRef]
  96. Reaz, A.H.; Saha, S.; Roy, C.K.; Wahab, M.A.; Will, G.; Amin, M.A.; Yamauchi, Y.; Liu, S.; Kaneti, Y.V.; Hossain, M.S.; et al. Boosting capacitive performance of manganese oxide nanorods by decorating with three-dimensional crushed graphene. Nano Converg. 2022, 9, 10. [Google Scholar] [CrossRef]
  97. Kim, H.; An, H.J.; Park, J.; Lee, Y.; Kim, M.S.; Lee, S.; Kim, N.D.; Song, J.; Choi, I. Ultrasensitive and real-time optical detection of cellular oxidative stress using graphene-covered tunable plasmonic interfaces. Nano Converg. 2022, 9, 23. [Google Scholar] [CrossRef]
  98. Chae, S.Y.; Park, R.; Hong, S.W. Surface-mediated high antioxidant and anti-inflammatory effects of astaxanthin-loaded ultrathin graphene oxide film that inhibits the overproduction of intracellular reactive oxygen species. Biomater. Res. 2022, 26, 30. [Google Scholar] [CrossRef]
  99. Kang, E.-S.; Kim, H.; Han, Y.; Cho, Y.-W.; Son, H.; Luo, Z.; Kim, T.-H. Enhancing osteogenesis of adipose-derived mesenchymal stem cells using gold nanostructure/peptide-nanopatterned graphene oxide. Colloids Surf. B Biointerfaces 2021, 204, 111807. [Google Scholar] [CrossRef]
  100. Park, D.; Park, J.; Lee, J.; Shim, C.J.; Kim, M.S.; Lee, T.Y.; Lim, J.O. Fabrication and characterization of graphene oxide-coated plate for efficient culture of stem cells. Tissue Eng. Regen. Med. 2021, 18, 775–785. [Google Scholar] [CrossRef]
  101. Kim, H.; Solak, K.; Han, Y.; Cho, Y.-W.; Koo, K.-M.; Kim, C.-D.; Luo, Z.; Son, H.; Kim, H.-R.; Mavi, A.; et al. Electrically controlled mRNA delivery using a polypyrrole-graphene oxide hybrid film to promote osteogenic differentiation of human mesenchymal stem cells. Nano Res. 2022, 15, 9253–9263. [Google Scholar] [CrossRef]
  102. Kang, E.-S.; Song, I.; Kim, D.-S.; Lee, U.; Kim, J.-K.; Son, H.; Min, J.; Kim, T.-H. Size-dependent effects of graphene oxide on the osteogenesis of human adipose-derived mesenchymal stem cells. Colloids Surf. B Biointerfaces 2018, 169, 20–29. [Google Scholar] [CrossRef] [PubMed]
  103. Gosnell, M.E.; Anwer, A.G.; Mahbub, S.B.; Perinchery, S.M.; Inglis, D.W.; Adhikary, P.P.; Jazayeri, J.A.; Cahill, M.A.; Saad, S.; Pollock, C.A.; et al. Quantitative non-invasive cell characterization and discrimination based on multispectral autofluorescence features. Sci. Rep. 2016, 6, 23453. [Google Scholar] [CrossRef] [PubMed]
  104. Castagnola, E.; Garg, R.; Rastogi, S.K.; Cohen-Karni, T.; Cui, X.T. 3D fuzzy graphene microelectrode array for dopamine sensing at sub-cellular spatial resolution. Biosens. Bioelectron. 2021, 191, 113440. [Google Scholar] [CrossRef] [PubMed]
  105. Vasudevan, S.; Kajtez, J.; Bunea, A.-I.; Gonzalez-Ramos, A.; Ramos-Moreno, T.; Heiskanen, A.; Kokaia, M.; Larsen, N.B.; Martínez-Serrano, A.; Keller, S.S.; et al. Leaky optoelectrical fiber for optogenetic stimulation and electrochemical detection of dopamine exocytosis from human dopaminergic neurons. Adv. Sci. 2019, 6, 1902011. [Google Scholar] [CrossRef]
  106. Pham Ba, V.A.; Cho, D.-G.; Hong, S. Nafion-radical hybrid films on carbon nanotube transistors for monitoring antipsychotic drug effects on stimulated dopamine release. ACS Appl. Mater. Interfaces 2019, 11, 9716–9723. [Google Scholar] [CrossRef]
  107. Whitesides, G.M. The origins and the future of microfluidics. Nature 2006, 442, 368–373. [Google Scholar] [CrossRef]
  108. Liu, K.-K.; Wu, R.-G.; Chuang, Y.-J.; Khoo, H.S.; Huang, S.-H.; Tseng, F.-G. Microfluidic systems for biosensing. Sensors 2010, 10, 6623–6661. [Google Scholar] [CrossRef]
  109. Rivet, C.; Lee, H.; Hirsch, A.; Hamilton, S.; Lu, H. Microfluidics for medical diagnostics and biosensors. Chem. Eng. Sci. 2011, 66, 1490–1507. [Google Scholar] [CrossRef]
  110. Luka, G.; Ahmadi, A.; Najjaran, H.; Alocilja, E.; DeRosa, M.; Wolthers, K.; Malki, A.; Aziz, H.; Althani, A.; Hoorfar, M. Microfluidics integrated biosensors: A leading technology towards lab-on-a-chip and sensing applications. Sensors 2015, 15, 30011–30031. [Google Scholar] [CrossRef]
  111. Rackus, D.G.; Shamsi, M.H.; Wheeler, A.R. Electrochemistry, biosensors and microfluidics: A convergence of fields. Chem. Soc. Rev. 2015, 44, 5320–5340. [Google Scholar] [CrossRef]
  112. Karimi, M.; Bahrami, S.; Mirshekari, H.; Basri, S.M.M.; Nik, A.B.; Aref, A.R.; Akbari, M.; Hamblin, M.R. Microfluidic systems for stem cell-based neural tissue engineering. Lab A Chip 2016, 16, 2551–2571. [Google Scholar] [CrossRef] [PubMed]
  113. Fan, W.; Chen, X.; Ge, Y.; Jin, Y.; Jin, Q.; Zhao, J. Single-cell impedance analysis of osteogenic differentiation by droplet-based microfluidics. Biosens. Bioelectron. 2019, 145, 111730. [Google Scholar] [CrossRef] [PubMed]
  114. Pelkonen, A.; Mzezewa, R.; Sukki, L.; Ryynänen, T.; Kreutzer, J.; Hyvärinen, T.; Vinogradov, A.; Aarnos, L.; Lekkala, J.; Kallio, P.; et al. A modular brain-on-a-chip for modelling epileptic seizures with functionally connected human neuronal networks. Biosens. Bioelectron. 2020, 168, 112553. [Google Scholar] [CrossRef] [PubMed]
  115. Lee, J.; Mehrotra, S.; Zare-Eelanjegh, E.; Rodrigues, R.O.; Akbarinejad, A.; Ge, D.; Amato, L.; Kiaee, K.; Fang, Y.; Rosenkranz, A.; et al. A heart-breast cancer-on-a-chip platform for disease modeling and monitoring of cardiotoxicity induced by cancer chemotherapy. Small 2021, 17, e2004258. [Google Scholar] [CrossRef] [PubMed]
  116. Huang, X.-J.; O’Mahony, A.M.; Compton, R.G. Microelectrode arrays for electrochemistry: Approaches to fabrication. Small 2009, 5, 776–788. [Google Scholar] [CrossRef] [PubMed]
  117. Farooqi, H.M.U.; Kang, B.; Khalid, M.A.U.; Salih, A.R.C.; Hyun, K.; Park, S.H.; Huh, D.; Choi, K.H. Real-time monitoring of liver fibrosis through embedded sensors in a microphysiological system. Nano Converg. 2021, 8, 3. [Google Scholar] [CrossRef] [PubMed]
  118. Ino, K.; Shiku, H.; Matsue, K. Bioelectrochemical applications of microelectrode arrays in cell analysis and engineering. Curr. Opin. Electrochem. 2017, 5, 146–151. [Google Scholar] [CrossRef]
  119. Fleischer, S.; Jahnke, H.-G.; Fritsche, E.; Girard, M.; Robitzki, A.A. Comprehensive human stem cell differentiation in a 2D and 3D mode to cardiomyocytes for long-term cultivation and multiparametric monitoring on a multimodal microelectrode array setup. Biosens. Bioelectron. 2019, 126, 624–631. [Google Scholar] [CrossRef]
  120. Gao, F.; Gao, K.; Zhang, P.; Fu, Y.; Liu, X.; Bai, S.; Li, W.; Qian, Z. A biomimetic sensor using neurotransmitter detection to decode odor perception by an olfactory network. Biosens. Bioelectron. 2022, 211, 114391. [Google Scholar] [CrossRef]
  121. He, E.; Zhou, Y.; Luo, J.; Xu, S.; Zhang, K.; Song, Y.; Wang, M.; Xu, S.; Dai, Y.; Yang, G.; et al. Sensitive detection of electrophysiology and dopamine vesicular exocytosis of hESC-derived dopaminergic neurons using multifunctional microelectrode array. Biosens. Bioelectron. 2022, 209, 114263. [Google Scholar] [CrossRef] [PubMed]
  122. Yang, X.; Yang, M.; Pang, B.; Vara, M.; Xia, Y. Gold nanomaterials at work in biomedicine. Chem. Rev. 2015, 115, 10410–10488. [Google Scholar] [CrossRef]
  123. Haiss, W.; Thanh, N.T.; Aveyard, J.; Fernig, D.G. Determination of size and concentration of gold nanoparticles from UV−Vis spectra. Anal. Chem. 2007, 79, 4215–4221. [Google Scholar] [CrossRef] [PubMed]
  124. Evanoff, D.D., Jr.; Chumanov, G. Synthesis and optical properties of silver nanoparticles and arrays. ChemPhysChem 2005, 6, 1221–1231. [Google Scholar] [CrossRef] [PubMed]
  125. Park, J.H.; Choe, H.-S.; Kim, S.-W.; Im, G.-B.; Um, S.H.; Kim, J.-H.; Bhang, S.H. Silica-capped and gold-decorated silica nanoparticles for enhancing effect of gold nanoparticle-based photothermal therapy. Tissue Eng. Regen. Med. 2022, 19, 1161–1168. [Google Scholar] [CrossRef] [PubMed]
  126. Lee, W.-J.; Kim, K.-J.; Hossain, M.K.; Cho, H.-Y.; Choi, J.-W. DNA–gold nanoparticle conjugates for intracellular miRNA detection using surface-enhanced Raman spectroscopy. BioChip J. 2022, 16, 33–40. [Google Scholar] [CrossRef]
  127. Michota, A.; Bukowska, J. Surface-enhanced Raman scattering (SERS) of 4-mercaptobenzoic acid on silver and gold substrates. J. Raman Spectrosc. 2003, 34, 21–25. [Google Scholar] [CrossRef]
  128. Cao, X.; Wang, Z.; Bi, L.; Bi, C.; Du, Q. Gold nanocage-based surface-enhanced Raman scattering probes for long-term monitoring of intracellular microRNA during bone marrow stem cell differentiation. Nanoscale 2020, 12, 1513–1527. [Google Scholar] [CrossRef]
  129. Sun, D.; Xu, W.; Liang, C.; Shi, W.; Xu, S. Smart surface-enhanced resonance Raman scattering nanoprobe for monitoring cellular alkaline phosphatase activity during osteogenic differentiation. ACS Sens. 2020, 5, 1758–1767. [Google Scholar] [CrossRef]
  130. Hua, S.; Zhong, S.; Arami, H.; He, J.; Zhong, D.; Zhang, D.; Chen, X.; Qian, J.; Hu, X.; Zhou, M. Simultaneous deep tracking of stem cells by surface enhanced Raman imaging combined with single-cell tracking by NIR-II imaging in myocardial infarction. Adv. Funct. Mater. 2021, 31, 2100468. [Google Scholar] [CrossRef]
  131. Lee, J.-H.; Choi, J.-H.; Chueng, S.-D.; Pongkulapa, T.; Yang, L.; Cho, H.-Y.; Choi, J.-W.; Lee, K.-B. Nondestructive characterization of stem cell neurogenesis by a magneto-plasmonic nanomaterial-based exosomal miRNA detection. ACS Nano 2019, 13, 8793–8803. [Google Scholar] [CrossRef]
  132. Yang, R.; Boldrey, J.; Jiles, D.; Schneider, I.; Que, L. On chip detection of glial cell-derived neurotrophic factor secreted from dopaminergic cells under magnetic stimulation. Biosens. Bioelectron. 2021, 182, 113179. [Google Scholar] [CrossRef] [PubMed]
  133. Ko, J.; Ham, J.; Lee, H.; Lee, K.; Koh, W.-G. Integration of a fiber-based cell culture and biosensing system for monitoring of multiple protein markers secreted from stem cells. Biosens. Bioelectron. 2021, 193, 113531. [Google Scholar] [CrossRef] [PubMed]
  134. Li, L.; Lu, Y.; Qian, Z.; Yang, Z.; Yang, K.; Zong, S.; Wang, Z.; Cui, Y. Ultra-sensitive surface enhanced Raman spectroscopy sensor for in-situ monitoring of dopamine release using zipper-like ortho-nanodimers. Biosens. Bioelectron. 2021, 180, 113100. [Google Scholar] [CrossRef] [PubMed]
  135. Wang, F.; Banerjee, D.; Liu, Y.; Chen, X.; Liu, X. Upconversion nanoparticles in biological labeling, imaging, and therapy. Analyst 2010, 135, 1839–1854. [Google Scholar] [CrossRef]
  136. Guller, A.E.; Generalova, A.N.; Petersen, E.V.; Nechaev, A.V.; Trusova, I.A.; Landyshev, N.N.; Nadort, A.; Grebenik, E.A.; Deyev, S.M.; Shekhter, A.B.; et al. Cytotoxicity and non-specific cellular uptake of bare and surface-modified upconversion nanoparticles in human skin cells. Nano Res. 2015, 8, 1546–1562. [Google Scholar] [CrossRef]
  137. Wang, K.; Wu, Q.; Wang, X.; Liang, G.; Yang, A.; Li, J. Near-infrared control and real-time detection of osteogenic differentiation in mesenchymal stem cells by multifunctional upconversion nanoparticles. Nanoscale 2020, 12, 10106–10116. [Google Scholar] [CrossRef]
  138. Yan, R.; Guo, Y.; Wang, X.; Liang, G.; Yang, A.; Li, J. Near-infrared light-controlled and real-time detection of osteogenic differentiation in mesenchymal stem cells by upconversion nanoparticles for osteoporosis therapy. ACS Nano 2022, 16, 8399–8418. [Google Scholar] [CrossRef]
  139. Rabie, H.; Zhang, Y.; Pasquale, N.; Lagos, M.J.; Batson, P.E.; Lee, K. NIR biosensing of neurotransmitters in stem cell-derived neural interface using advanced core–shell upconversion nanoparticles. Adv. Mater. 2019, 31, e1806991. [Google Scholar] [CrossRef]
  140. Andersson, H.; Baechi, T.; Hoechl, M.; Richter, C. Autofluorescence of living cells. J. Microsc. 1998, 191 Pt 1, 1–7. [Google Scholar] [CrossRef]
  141. Zhao, J.; Lui, H.; McLean, D.I.; Zeng, H. Automated autofluorescence background subtraction algorithm for biomedical Raman spectroscopy. Appl. Spectrosc. 2007, 61, 1225–1232. [Google Scholar] [CrossRef]
  142. Paras, C.; Keller, M.; White, L.; Phay, J.; Mahadevan-Jansen, A. Near-infrared autofluorescence for the detection of parathyroid glands. J. Biomed. Opt. 2011, 16, 067012. [Google Scholar] [CrossRef] [PubMed]
  143. Qian, T.; Heaster, T.M.; Houghtaling, A.R.; Sun, K.; Samimi, K.; Skala, M.C. Label-free imaging for quality control of cardiomyocyte differentiation. Nat. Commun. 2021, 12, 4580. [Google Scholar] [CrossRef] [PubMed]
  144. Suhito, I.R.; Han, Y.; Ryu, Y.-S.; Son, H.; Kim, T.-H. Autofluorescence-Raman Mapping Integration analysis for ultra-fast label-free monitoring of adipogenic differentiation of stem cells. Biosens. Bioelectron. 2021, 178, 113018. [Google Scholar] [CrossRef] [PubMed]
  145. Li, J.; Reimers, A.; Dang, K.M.; Brunk, M.G.K.; Drewes, J.; Hirsch, U.M.; Willems, C.; Schmelzer, C.E.H.; Growth, T.; Nia, A.S.; et al. 3D printed neural tissues with in situ optical dopamine sensors. Biosens. Bioelectron. 2023, 222, 114942. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic illustration of traditional sensing and nano- and micromaterial-based methods for monitoring stem cell differentiation. Created with BioRender.com.
Figure 1. Schematic illustration of traditional sensing and nano- and micromaterial-based methods for monitoring stem cell differentiation. Created with BioRender.com.
Biosensors 13 00501 g001
Figure 2. Gold nanoparticle-based electrochemical sensors. (a) Characterisation of gold nanoassembly and magnetic nanoparticles. (b) Time-dependent monitoring of osteogenesis using the gold nanoassembly-based electrochemical sensors. (c,d) DPV results of iPSCs differentiation and organoid generation on gold-based electrochemical electrode. Reprinted with permission from [74]. Copyright 2021, Wiley Online Library; Reprinted with permission from [75]. Copyright 2022, Wiley Online Library. AuNPs, gold nanoparticles; DPV, differential pulse voltammetry; Fe3O4, iron (II, III) oxide; iPSCs, induced pluripotent stem cells. N.S. indicates “not significant.” ** p < 0.01, and *** p < 0.001.
Figure 2. Gold nanoparticle-based electrochemical sensors. (a) Characterisation of gold nanoassembly and magnetic nanoparticles. (b) Time-dependent monitoring of osteogenesis using the gold nanoassembly-based electrochemical sensors. (c,d) DPV results of iPSCs differentiation and organoid generation on gold-based electrochemical electrode. Reprinted with permission from [74]. Copyright 2021, Wiley Online Library; Reprinted with permission from [75]. Copyright 2022, Wiley Online Library. AuNPs, gold nanoparticles; DPV, differential pulse voltammetry; Fe3O4, iron (II, III) oxide; iPSCs, induced pluripotent stem cells. N.S. indicates “not significant.” ** p < 0.01, and *** p < 0.001.
Biosensors 13 00501 g002
Figure 3. Aptamer-based electrochemical sensors. (a,b) ECL images of neurons injected in the micro-well and DA aptamer-based electrochemical sensor. (c,d) Analysis of DA sensing capability of micro-well and DA aptamer-based electrochemical sensor. Reprinted with permission from [91]. 5-HT, 5-hydroxytryptamine; Ag, silver; AgCl silver chloride; Au, gold; DA, dopamine; ECL, electrochemical luminescence; RSD, relative standard deviation.
Figure 3. Aptamer-based electrochemical sensors. (a,b) ECL images of neurons injected in the micro-well and DA aptamer-based electrochemical sensor. (c,d) Analysis of DA sensing capability of micro-well and DA aptamer-based electrochemical sensor. Reprinted with permission from [91]. 5-HT, 5-hydroxytryptamine; Ag, silver; AgCl silver chloride; Au, gold; DA, dopamine; ECL, electrochemical luminescence; RSD, relative standard deviation.
Biosensors 13 00501 g003
Figure 4. A carbon fibre-based electrochemical sensor for monitoring in vitro neurogenesis. (a) Immunocytochemistry images of hNSCs-derived dopaminergic neurons cultured on the sensor. (b) Amperometry graph of non-differentiated and differentiated cells after stimulating DA exocytosis. (c) Electrochemical current peaks toward DA for time-dependent monitoring of the dopaminergic differentiation on the sensor. Reprinted with permission from [105]. Copyright 2019, Wiley Online Library. DA, dopamine; DNA, deoxyribonucleic acid; hNSCs, human neural stem cells; TH, tyrosine hydroxylase.
Figure 4. A carbon fibre-based electrochemical sensor for monitoring in vitro neurogenesis. (a) Immunocytochemistry images of hNSCs-derived dopaminergic neurons cultured on the sensor. (b) Amperometry graph of non-differentiated and differentiated cells after stimulating DA exocytosis. (c) Electrochemical current peaks toward DA for time-dependent monitoring of the dopaminergic differentiation on the sensor. Reprinted with permission from [105]. Copyright 2019, Wiley Online Library. DA, dopamine; DNA, deoxyribonucleic acid; hNSCs, human neural stem cells; TH, tyrosine hydroxylase.
Biosensors 13 00501 g004
Figure 5. A microfluidic system-based electrochemical sensor for monitoring cardiomyocyte differentiation. (a) A schematic illustration showing an aptamer and microfluidic system-based electrochemical sensor. (b) Analysis of the important role of interaction between cardiac and heart cancer tissues through biomarkers sensing. (c) Monitoring of cardiotoxicity-associated biomarkers using the aptamer and microfluidic system-based electrochemical sensor. Reprinted with permission from [115]. Copyright 2020, Wiley Online Library. DOX, doxorubicin; HER2, human epidermal growth factor receptor 2; TGFβ1, transforming growth factor beta 1.* p < 0.05, ** p < 0.01, and *** p < 0.001.
Figure 5. A microfluidic system-based electrochemical sensor for monitoring cardiomyocyte differentiation. (a) A schematic illustration showing an aptamer and microfluidic system-based electrochemical sensor. (b) Analysis of the important role of interaction between cardiac and heart cancer tissues through biomarkers sensing. (c) Monitoring of cardiotoxicity-associated biomarkers using the aptamer and microfluidic system-based electrochemical sensor. Reprinted with permission from [115]. Copyright 2020, Wiley Online Library. DOX, doxorubicin; HER2, human epidermal growth factor receptor 2; TGFβ1, transforming growth factor beta 1.* p < 0.05, ** p < 0.01, and *** p < 0.001.
Biosensors 13 00501 g005
Figure 6. A microelectrode array-based electrochemical sensor. (a) Analysis of dopaminergic differentiation of hESCs cultured on the platform. (b) Detection of DA exocytosis on the platform. Reprinted with permission from [121]. Copyright 2022, Elsevier. DA, dopamine; DAPI, 4′,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; hESCs, human embryonic stem cells; mRNA, messenger ribonucleic acid; TH, tyrosine hydroxylase. “n.d.”, indicates non-detected; “n.s.”, indicates non-significant; ** p < 0.01, *** p < 0.001.
Figure 6. A microelectrode array-based electrochemical sensor. (a) Analysis of dopaminergic differentiation of hESCs cultured on the platform. (b) Detection of DA exocytosis on the platform. Reprinted with permission from [121]. Copyright 2022, Elsevier. DA, dopamine; DAPI, 4′,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; hESCs, human embryonic stem cells; mRNA, messenger ribonucleic acid; TH, tyrosine hydroxylase. “n.d.”, indicates non-detected; “n.s.”, indicates non-significant; ** p < 0.01, *** p < 0.001.
Biosensors 13 00501 g006
Figure 7. A gold-based NIR sensor for monitoring of chondrogenic differentiation. (a) Characterisation of the AuStar-DTTC-Ag2S (GDS) nanoparticles. (b) Ex vivo Raman imaging of GDS-MSCs in a myocardial infarction model. Reprinted with permission from [130]. Copyright 2020, Wiley Online Library. Ag, silver; Ag2S, silver sulphide; Au, gold; AuStar, gold nanostar; BSA, bovine serum albumen; DMEM, Dulbecco’s modified eagle medium; DTTC, 3.3′-diethylthiatricarbocyanine iodide; GFP, green fluorescent protein; MSCs, mesenchymal stem cells; NIR, near-infrared; PBS, phosphate-buffered saline; S, sulphur; SERS, surface-enhanced Raman spectroscopy.
Figure 7. A gold-based NIR sensor for monitoring of chondrogenic differentiation. (a) Characterisation of the AuStar-DTTC-Ag2S (GDS) nanoparticles. (b) Ex vivo Raman imaging of GDS-MSCs in a myocardial infarction model. Reprinted with permission from [130]. Copyright 2020, Wiley Online Library. Ag, silver; Ag2S, silver sulphide; Au, gold; AuStar, gold nanostar; BSA, bovine serum albumen; DMEM, Dulbecco’s modified eagle medium; DTTC, 3.3′-diethylthiatricarbocyanine iodide; GFP, green fluorescent protein; MSCs, mesenchymal stem cells; NIR, near-infrared; PBS, phosphate-buffered saline; S, sulphur; SERS, surface-enhanced Raman spectroscopy.
Biosensors 13 00501 g007
Figure 8. Upconversion nanoparticle-based optical sensor capable of monitoring neurogenesis. (a) Upconversion luminescence profiles and analysis of the operating mechanism and characteristics of UCNPs for each condition. (b) Monitoring of neuronal differentiation of hNSCs using the UCNPs-based optical sensor. Reprinted with permission from [139]. Copyright 2019, Wiley Online Library. cAMP, cyclic adenosine monophosphate; DA, dopamine; GDNF, neurotrophic factor; GO, graphene oxide; hNSCs, human neural stem cells; NIR, near-infrared; UCNPs, upconversion nanoparticles. ** p < 0.01.
Figure 8. Upconversion nanoparticle-based optical sensor capable of monitoring neurogenesis. (a) Upconversion luminescence profiles and analysis of the operating mechanism and characteristics of UCNPs for each condition. (b) Monitoring of neuronal differentiation of hNSCs using the UCNPs-based optical sensor. Reprinted with permission from [139]. Copyright 2019, Wiley Online Library. cAMP, cyclic adenosine monophosphate; DA, dopamine; GDNF, neurotrophic factor; GO, graphene oxide; hNSCs, human neural stem cells; NIR, near-infrared; UCNPs, upconversion nanoparticles. ** p < 0.01.
Biosensors 13 00501 g008
Figure 9. An autofluorescence imaging for monitoring of cardiomyocyte differentiation. Single-cell quantitative analysis of NAD(P)H during 8 days of the differentiation period. Reprinted with permission from [143]. Copyright 2019, Wiley Online Library. EGFP, enhanced green fluorescent protein; NAD(P)H, reduced nicotinamide adenine dinucleotide (phosphate); NKX2.5-EGFP, homeobox protein NKX2.5-EGFP.**** p < 0.0001.
Figure 9. An autofluorescence imaging for monitoring of cardiomyocyte differentiation. Single-cell quantitative analysis of NAD(P)H during 8 days of the differentiation period. Reprinted with permission from [143]. Copyright 2019, Wiley Online Library. EGFP, enhanced green fluorescent protein; NAD(P)H, reduced nicotinamide adenine dinucleotide (phosphate); NKX2.5-EGFP, homeobox protein NKX2.5-EGFP.**** p < 0.0001.
Biosensors 13 00501 g009
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kang, M.-J.; Cho, Y.-W.; Kim, T.-H. Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation. Biosensors 2023, 13, 501. https://doi.org/10.3390/bios13050501

AMA Style

Kang M-J, Cho Y-W, Kim T-H. Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation. Biosensors. 2023; 13(5):501. https://doi.org/10.3390/bios13050501

Chicago/Turabian Style

Kang, Min-Ji, Yeon-Woo Cho, and Tae-Hyung Kim. 2023. "Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation" Biosensors 13, no. 5: 501. https://doi.org/10.3390/bios13050501

APA Style

Kang, M. -J., Cho, Y. -W., & Kim, T. -H. (2023). Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation. Biosensors, 13(5), 501. https://doi.org/10.3390/bios13050501

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop